<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2017.00232</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Interplay of Energetics and ER Stress Exacerbates Alzheimer&#x00027;s Amyloid-&#x003B2; (A&#x003B2;) Toxicity in Yeast</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Xin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn004"><sup>&#x02021;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/428903/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Bisschops</surname> <given-names>Markus M. M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<xref ref-type="author-notes" rid="fn004"><sup>&#x02021;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/434462/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Agarwal</surname> <given-names>Nisha R.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/460175/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ji</surname> <given-names>Boyang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/200350/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Shanmugavel</surname> <given-names>Kumaravel P.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/429443/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Petranovic</surname> <given-names>Dina</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/73835/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Division of Systems and Synthetic Biology, Department of Biology and Biological Engineering, Chalmers University of Technology</institution> <country>Gothenburg, Sweden</country></aff>
<aff id="aff2"><sup>2</sup><institution>Division of Chemical Biology, Department of Biology and Biological Engineering, Chalmers University of Technology</institution> <country>Gothenburg, Sweden</country></aff>
<aff id="aff3"><sup>3</sup><institution>Novo Nordisk Foundation Center for Biosustainability, Chalmers University of Technology</institution> <country>Gothenburg, Sweden</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Ralf J. Braun, University of Bayreuth, Germany</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Julia Ring, University of Graz, Austria; Vanessa Franssens, KU Leuven, Belgium; Bruce Morgan, Kaiserslautern University of Technology, Germany</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Dina Petranovic <email>dina.petranovic&#x00040;chalmers.se</email></p></fn>
<fn fn-type="present-address" id="fn002"><p>&#x02020;Present Address: Markus M. M. Bisschops, Department of Biotechnology, Delft University of Technology, Delft, Netherlands;</p></fn>
<fn fn-type="present-address" id="fn003"><p>Nisha R. Agarwal, Department of Chemistry and Chemical Biology, Biointerfaces Institute, McMaster University, Hamilton, Ontario, CA, Canada</p></fn>
<fn fn-type="other" id="fn004"><p>&#x02021;These authors have contributed equally to this work.</p></fn></author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>07</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>10</volume>
<elocation-id>232</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>04</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>07</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Chen, Bisschops, Agarwal, Ji, Shanmugavel and Petranovic.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Chen, Bisschops, Agarwal, Ji, Shanmugavel and Petranovic</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Alzheimer&#x00027;s disease (AD) is a progressive neurodegeneration. Oligomers of amyloid-&#x003B2; peptides (A&#x003B2;) are thought to play a pivotal role in AD pathogenesis, yet the mechanisms involved remain unclear. Two major isoforms of A&#x003B2; associated with AD are A&#x003B2;40 and A&#x003B2;42, the latter being more toxic and prone to form oligomers. Here, we took a systems biology approach to study two humanized yeast AD models which expressed either A&#x003B2;40 or A&#x003B2;42 in bioreactor cultures. Strict control of oxygen availability and culture pH, strongly affected chronological lifespan and reduced variations during cell growth. Reduced growth rates and biomass yields were observed upon A&#x003B2;42 expression, indicating a redirection of energy from growth to maintenance. Quantitative physiology analyses furthermore revealed reduced mitochondrial functionality and ATP generation in A&#x003B2;42 expressing cells, which matched with observed aberrant mitochondrial structures. Genome-wide expression level analysis showed that A&#x003B2;42 expression triggered strong ER stress and unfolded protein responses. Equivalent expression of A&#x003B2;40, however, induced only mild ER stress, which resulted in hardly affected physiology. Using AD yeast models in well-controlled cultures strengthened our understanding on how cells translate different A&#x003B2; toxicity signals into particular cell fate programs, and further enhance their potential as a discovery platform to identify possible therapies.</p>
</abstract>
<kwd-group>
<kwd>amyloid-&#x003B2;</kwd>
<kwd>Alzheimer&#x00027;s disease</kwd>
<kwd>energetics</kwd>
<kwd>ER stress</kwd>
<kwd>yeast</kwd>
</kwd-group>
<contract-num rid="cn001">21210022</contract-num>
<contract-sponsor id="cn001">Novo Nordisk<named-content content-type="fundref-id">10.13039/501100004191</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<equation-count count="1"/>
<ref-count count="107"/>
<page-count count="16"/>
<word-count count="12950"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Alzheimer&#x00027;s disease (AD) is the most common form of neurodegenerative disorder, and its incidence is projected to rise due to the increasing life expectancy (Wyss-Coray, <xref ref-type="bibr" rid="B101">2016</xref>). Due to incomplete knowledge on the underlying mechanisms that lead to cellular dysfunction in AD, it is difficult to design effective therapies. Accumulation of amyloid-&#x003B2; (A&#x003B2;) plaques in the brain is a key neuropathological feature of AD (Hardy and Selkoe, <xref ref-type="bibr" rid="B30">2002</xref>). A&#x003B2; peptides (ranging in length from 39 to 43 amino acids) are generated by amyloidogenic processing of the transmembrane amyloid precursor protein (APP; Selkoe, <xref ref-type="bibr" rid="B79">2001</xref>). Differential cleavage of APP produces two major A&#x003B2; peptide isoforms, A&#x003B2;40 and A&#x003B2;42, of which A&#x003B2;40 is most abundantly produced, but A&#x003B2;42 is the predominant isoform found in AD plaques (Younkin, <xref ref-type="bibr" rid="B104">1998</xref>). A&#x003B2;42 is also more hydrophobic and prone to aggregation than A&#x003B2;40 (Jarrett et al., <xref ref-type="bibr" rid="B40">1993</xref>). Increasing evidence suggests that oligomeric species of A&#x003B2; are the most toxic forms (McLean et al., <xref ref-type="bibr" rid="B57">1999</xref>; Shankar et al., <xref ref-type="bibr" rid="B80">2008</xref>) and the accumulation of intracellular A&#x003B2;42 oligomers may be an early event in AD pathogenesis (Gouras et al., <xref ref-type="bibr" rid="B28">2005</xref>).</p>
<p>The strong conservation of the cellular protein quality control system between yeast and human, combined with its genetic accessibility and ease of manipulation and cultivation, make the yeast <italic>Saccharomyces cerevisiae</italic> a powerful model organism to study protein-misfolding pathologies caused by A&#x003B2; (Khurana and Lindquist, <xref ref-type="bibr" rid="B46">2010</xref>). Over the past two decades, several humanized yeast models have been developed to study A&#x003B2; toxicity (Fruhmann et al., <xref ref-type="bibr" rid="B26">2017</xref>). The earlier models have been successfully used to monitor aggregation patterns of A&#x003B2; (Bagriantsev and Liebman, <xref ref-type="bibr" rid="B4">2006</xref>; von der Haar et al., <xref ref-type="bibr" rid="B97">2007</xref>), but failed to recapitulate its toxic effects. More recently developed models illustrated the importance of intracellular trafficking for A&#x003B2; toxicity (Treusch et al., <xref ref-type="bibr" rid="B92">2011</xref>; D&#x00027;Angelo et al., <xref ref-type="bibr" rid="B20">2013</xref>). In neurons, APP is processed to generate A&#x003B2; peptides through the secretory pathway as well as the endocytic pathway (Thinakaran and Koo, <xref ref-type="bibr" rid="B90">2008</xref>). This progression through different intracellular organelles and vesicles has been recapitulated in yeast by fusion of the A&#x003B2; peptide to secretion signal sequences, i.e., the Kar2 or &#x003B1;-prepro targeting signals (Treusch et al., <xref ref-type="bibr" rid="B92">2011</xref>; D&#x00027;Angelo et al., <xref ref-type="bibr" rid="B20">2013</xref>). Expression of human A&#x003B2; peptides with the ER Kar2 signal ensures that A&#x003B2; peptides transit through the secretory pathway and are eventually exported from the cytoplasm. However, the yeast cell wall prevents secreted A&#x003B2; from diffusing away, and A&#x003B2; peptides re-enter into the cell through endocytosis (Treusch et al., <xref ref-type="bibr" rid="B92">2011</xref>). Similar to observations in human neurons and other AD model organisms (Luheshi et al., <xref ref-type="bibr" rid="B51">2007</xref>), A&#x003B2;42 peptides form more oligomers than A&#x003B2;40 and exhibit an increased cellular toxicity in yeast (Treusch et al., <xref ref-type="bibr" rid="B92">2011</xref>). These models captured important aspects of A&#x003B2; toxicity and identified the yeast homologs of phosphatidylinositol binding clathrin assembly protein (<italic>PICALM</italic>) and other endocytic factors to be involved in A&#x003B2; toxicity (Treusch et al., <xref ref-type="bibr" rid="B92">2011</xref>; D&#x00027;Angelo et al., <xref ref-type="bibr" rid="B20">2013</xref>; Verduyckt et al., <xref ref-type="bibr" rid="B95">2016</xref>).</p>
<p>Although these models capture the cellular trafficking processes essential to A&#x003B2; toxicity, the heterologous A&#x003B2; expression in yeast is different from native expression in human neurons. In humanized yeast models, expression of A&#x003B2; peptides is often under control of a strong inducible promotor, whereas the production in neurons is constitutively. This inducible type of expression allows for well-timed induction of acute cytotoxicity, but is accompanied by a drastic change in carbon-source and hence metabolism, and excludes capturing effects of cellular aging or cumulative effects on toxicity. To avoid these drawbacks, we developed a continuous and tightly regulated A&#x003B2; expression model, which mimicked the chronic cytotoxicity that occurs during AD progression better. In our model, we successfully expressed human A&#x003B2; peptides (A&#x003B2;40 and A&#x003B2;42) in a constitutive manner, resulting in a shorter chronological life span (CLS) and increased oxidative stress. Furthermore, strong links between mitochondrial dysfunction and reduced proteasome activity were observed upon mild expression of A&#x003B2;42 peptide (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>). Here, we take advantage of this improved humanized yeast model to further exploit the effects of A&#x003B2; on cellular functioning, viability and energetics following a systems biology approach.</p>
<p>The complexity of AD is illustrated by the continued interplay of unbalanced networks and homeostatic networks in neurons (Castrillo and Oliver, <xref ref-type="bibr" rid="B15">2015</xref>). To capture these dynamics at the molecular and cellular level, time-course analyses of yeast A&#x003B2; models are needed. A crucial prerequisite to extract relevant information from the large amount of data obtained (e.g., genome-wide expression profile analysis), is minimization of confounding variables. The widely used shake-flask or tube cultures suffer from several important drawbacks, including lack of online monitoring and continuous control of cultivation parameters (Kl&#x000F6;ckner and B&#x000FC;chs, <xref ref-type="bibr" rid="B47">2012</xref>), that influence cell growth and physiology and thus hinder data interpretation (Burtner et al., <xref ref-type="bibr" rid="B13">2011</xref>). Therefore, we considered bioreactors an optimal system in which parameters can be continuously monitored and controlled. In addition, analysis of in- and off-gas compositions, aids in evaluating the energetic efficiencies of growth. Monitoring these parameters is relevant for <italic>S. cerevisiae</italic> as a model organism to estimate the interplay of metabolism, energetics, and mitochondrial functions. The typical growth curve consists of an initially predominantly fermentative, fast exponential growth phase (EX) until glucose is exhausted. Then it is followed by slower, fully respiratory growth on ethanol, glycerol, and organic acids during the post-diauxic shift phase (PD). Finally, growth is arrested due to depletion of extracellular carbon sources and the culture enters stationary phase (SP). Transition through these phases heavily depends on culture conditions (Herman, <xref ref-type="bibr" rid="B32">2002</xref>) and strongly influences cell survival during SP (Bisschops et al., <xref ref-type="bibr" rid="B9">2015</xref>). Although bioreactor cultivation offers strong advantages over more simple culture techniques, it is rarely applied in studies of humanized yeast models.</p>
<p>Subjecting our improved humanized A&#x003B2; yeast model to strictly controlled and monitored bioreactor environments, allow us, for the first time, to study how cell physiology and genome-wide expression levels are affected by different A&#x003B2; variants over time (Figure <xref ref-type="fig" rid="F1">1</xref>). By controlling the culture parameters, we reduced the number of irrelevant and sidetracking variables and produced a considerable amount of genome-wide and physiological information concerning the energetic consequences of A&#x003B2; expression, as well as revealing how these different A&#x003B2; toxic isoforms interfered with cellular metabolism and stress response pathways, causing pronounced physiological effects.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Schematic workflow for the integrated analysis of A&#x003B2;-induced cytotoxicity in <italic>S. cerevisiae</italic>. <bold>(A)</bold> Batch cultures of control, A&#x003B2;42 and A&#x003B2;40 expressing strains were grown and compared in well-controlled bioreactors. <bold>(B)</bold> Biomass, glucose (&#x02022;), and ethanol (&#x00394;) concentrations were measured and used to divide growth into exponential (EX), post-diauxic shift (PD), and stationary phases (SP). Time-points of specific analyses mentioned in <bold>(C)</bold> are indicated by <sup>&#x0002B;</sup> and <sup>&#x0002A;</sup>. <bold>(C)</bold> Samples were taken for analysis of physiology, lipidome, and transcriptome during different growth phases. <bold>(D)</bold> The data obtained were collected and integrated, resulting in an overall biological interpretation of intracellular A&#x003B2; toxicity.</p></caption>
<graphic xlink:href="fnmol-10-00232-g0001.tif"/>
</fig>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Yeast strains and plasmids</title>
<p>The auxotrophic yeast <italic>S. cerevisiae</italic> strain CEN.PK.113-5D (<italic>MATa ura3-52 HIS3, LEU2 TRP1 MAL2-8</italic><sup><italic>c</italic></sup> <italic>SUC2</italic>; kindly provided by Dr. P. K&#x000F6;tter, University of Frankfurt, Germany; Entian and K&#x000F6;tter, <xref ref-type="bibr" rid="B23">2007</xref>) was used as a host strain in this study. The host strain was transformed with the plasmids for constitutive and equivalent expression of A&#x003B2;42 and A&#x003B2;40, under control of the <italic>GPD1</italic> promoter: p416GPD-A&#x003B2;42 and p416GPD-A&#x003B2;40, respectively. The detailed construction of these plasmids and strains has been reported previously (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>). Both A&#x003B2; constructs consist of the Kar2 signal sequence (42 amino acids) in front of A&#x003B2;42 or A&#x003B2;40 sequence, as described previously (Treusch et al., <xref ref-type="bibr" rid="B92">2011</xref>).</p>
</sec>
<sec>
<title>Batch cultivation</title>
<p>Strains were grown in defined minimal medium as described previously (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>), containing per liter: 10 g glucose, 5 g (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 3 g KH<sub>2</sub>PO<sub>4</sub>, 0.5 g MgSO<sub>4</sub>.7H<sub>2</sub>O, 125 &#x003BC;l antifoam 204 (Sigma-Aldrich, USA), trace metals solution, and vitamins. Trace metals and vitamins solutions were prepared as described previously (Jensen et al., <xref ref-type="bibr" rid="B41">2014</xref>). Batch fermentations were performed at 30&#x000B0;C in 1.2-l bioreactors (DasGip, Germany) with a working volume of 700 ml. Cultures were operated with 800 rpm agitation and 1 vvm gas flow of either pure dried air (aerobic) or dried air mixed with nitrogen gas to obtain a mixture containing 2% oxygen (micro-aerobic). Culture pH was measured with a pH sensor (Mettler Toledo, Switzerland) and maintained at 5.0 by automated addition of 2 M KOH or 2 M H<sub>2</sub>SO<sub>4</sub>. The CO<sub>2</sub> and O<sub>2</sub> concentrations in the exhaust gas were analyzed real-time with a GA4 gas analyzer (DasGip, Germany).</p>
</sec>
<sec>
<title>Determination of biomass and extracellular metabolites</title>
<p>Biomass and extracellular metabolites were determined as described previously (Zhou et al., <xref ref-type="bibr" rid="B107">2016</xref>). Biomass concentrations were measured as the optical density at 600 nm (OD<sub>600</sub>) and cell dry weight (CDW). CDW was measured by filtering 5 ml of culture samples over a pre-weighted, pre-dried 0.45 &#x003BC;m nitrocellulose filter (Sartorius Stedim, Germany), microwave drying of the filter plus biomass and determining the increase in weight of the dried filter. During the different growth phases, OD/CDW ratios were constant (1.45 &#x000B1; 0.04 OD/g l<sup>&#x02212;1</sup>). Extracellular glucose, ethanol, glycerol and acetate concentrations were analyzed on an Ultimate 3000 HPLC (Dionex, Sunnyvale, USA) equipped with an Aminex HPX-87H column (Bio Rad, USA). The column was eluted at 45&#x000B0;C using 5 mM H<sub>2</sub>SO<sub>4</sub> at a flow rate of 0.6 ml min<sup>&#x02212;1</sup>.</p>
</sec>
<sec>
<title>Glycogen and trehalose assays</title>
<p>Ten OD<sub>600</sub> of cells were harvested by centrifugation at 2,000 &#x000D7; <italic>g</italic> for 5 min at 4&#x000B0;C, and washed once in ice-cold distilled water. Cell pellets were resuspended in boiling 0.25 M Na<sub>2</sub>CO<sub>3</sub> solution and processed as described previously (Parrou and Fran&#x000E7;ois, <xref ref-type="bibr" rid="B69">1997</xref>). Glycogen and trehalose were converted into glucose with amyloglucosidase (Sigma-Aldrich) and trehalase (Sigma-Aldrich), respectively, in acidic environment (pH 5.2). Glucose levels were determined enzymatically using a Glucose (HK) assay kit (Sigma-Aldrich).</p>
</sec>
<sec>
<title>Viability and reactive oxygen species (ROS) measurement</title>
<p>Viability and intracellular ROS were measured by propidium iodide (PI, Thermo Fisher Scientific, USA) and dihydrorhodamine 123 (DHR123, Sigma-Aldrich, USA) staining respectively, as described previously (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>). For the staining, 0.5 OD<sub>600</sub> of cells were taken at different phases and incubated with 0.5 &#x003BC;g ml<sup>&#x02212;1</sup> of PI or 5 &#x003BC;M of DHR123 for 20 min. Cells were analyzed with a Guava flow cytometer (Merck, Germany) using a 488 nm laser for excitation. Fluorescence was detected with a 690/50 filter for PI or a 525/30 nm filter for rhodamine 123. Five thousand cells were analyzed for each sample. Two populations could be distinguished based on fluorescence intensity. Positively stained cells fall within the more fluorescent population (mean fluorescence 5&#x02013;100 times higher). Results are shown as the fractions stained positively by PI or DHR123.</p>
</sec>
<sec>
<title>Determination of respiratory capacity</title>
<p>Five OD<sub>600</sub> of cells were harvested, washed twice in distilled water and resuspended in PBS before measurement. Oxygen consumption was measured at 30&#x000B0;C in a 1 ml temperature controlled closed chamber with a Clark oxygen electrode (Gilson) as described previously (Albers et al., <xref ref-type="bibr" rid="B2">2007</xref>). One milliliter of PBS was added to the chamber and incubated until baseline (100% dissolved O<sub>2</sub>) was stable. One OD<sub>600</sub> of cells were added to the chamber to measure the endogenous oxygen consumption rate. When the rate was stable, 25 mM of glucose was added to the chamber to obtain the initial oxygen consumption rate with glucose. Sodium thiosulfate (NaS<sub>2</sub>O<sub>3</sub>) was used for the zero-point calibration of the sensors. Oxygen consumption rates were determined from the slope of a plot of oxygen concentration vs. time and expressed as mM/OD/h.</p>
</sec>
<sec>
<title>Non-linear microscopy</title>
<p>One OD<sub>600</sub> of cells were harvested during PD. Mitochondria were stained with 1 &#x003BC;g ml<sup>&#x02212;1</sup> Rhodamine 123 (Rh123, Sigma-Aldrich, USA) for 30 min and washed once in PBS. One OD<sub>600</sub> of cells was harvested during EX for lipid droplets measurement. Non-linear microscopy was applied to detect lipid droplets and mitochondria signals as described previously (Mertz, <xref ref-type="bibr" rid="B58">2004</xref>). Two laser beams, 817 (5 mW) and 1,064 nm (6 mW) of synchronized pico-second pulse trains were spatially and temporally overlapped to be coupled into an inverted Nikon microscope (Eclipse TE2000-E microscope). CARS and TPEF signals were generated in live yeast cells to monitor lipid droplets and Rh123 stained mitochondria, respectively. The laser beams were focused on the samples using a 40x objective (Nikon Plan Fluor N.A. 1.3, working distance 0.21 mm). CARS and TPEF signals were collected in forward and epi-direction, respectively, with a high NA lens with a 661/20 and 514/30 or 609/45 filter into a single photon counting (SPC) photomultiplier tube (HPM-100-40, Becker &#x00026; Hickl GmbH). Z-stacks were acquired for each sample with 0.2 &#x003BC;m step size for a maximum of 10 &#x003BC;m sample thickness. Each single acquisition in the z-stack was taken in 1 sec with a resolution of 256 pixels for a 34.4 &#x003BC;m field of view. The images were opened in ImageJ and then processed in Imaris (Bitplane software for image processing). The lipid quantification for control and A&#x003B2;42 expressing cells was done by ImageJ and GIMP (GNU Image Manipulation Program). Statistics was performed for 10 images of each strain. The quantities were determined from the CARS channel in which lipids were detected. The channel was turned into a binary color format (0 and 1) in GIMP first for lipids and their area in each slice (Li, i &#x0003D; slice number) was calculated using ImageJ. Subsequently cell areas in each slice (Ci, i &#x0003D; slice number) were also calculated. The ratio of the summation of lipid area / summation of cell area gave the value of lipid content in a cell as shown in Equation 1. The distance between slices (&#x00394;z) was canceled out since it was constant for all cells.</p>
<disp-formula id="E1"><label>(1)</label><mml:math id="M1"><mml:mtable class="eqnarray" columnalign="right center left"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mstyle displaystyle='true'><mml:msub><mml:mo>&#x02211;</mml:mo><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mi>L</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:mstyle></mml:mrow><mml:mrow><mml:mstyle displaystyle='true'><mml:msub><mml:mo>&#x02211;</mml:mo><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mi>C</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:mstyle></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>V</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mo>&#x000A0;</mml:mo><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mo>&#x000A0;</mml:mo><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>s</mml:mi><mml:mo>&#x000A0;</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>&#x000A0;</mml:mo><mml:mi>a</mml:mi><mml:mo>&#x000A0;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>&#x000A0;</mml:mo><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x000A0;</mml:mo><mml:mi>v</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
</sec>
<sec>
<title>Transcriptome analysis</title>
<p>Samples for microarray analysis were taken from duplicate cultures during EX, PD, SP1, and SP2, respectively. Samples of cells were frozen rapidly in liquid nitrogen to prevent mRNA turnover (Piper et al., <xref ref-type="bibr" rid="B71">2002</xref>). Total RNA was extracted using the RNeasy Mini Kit (QIAGEN, Germany) with a FastPrep homogenizer (MP Biomedicals, USA) to disrupt cells. Quality of total RNA was assessed by an Agilent 2100 bioanalyzer (Agilent Technologies, USA). Further RNA preparation and hybridization of biotin-conjugated aRNA fragments to Yeast Genome 2.0 Arrays (Affymetrix GeneChip, USA) was performed by the Bioinformatics and Expression Analysis core facility (BEA) of the Karolinska Institute, Sweden. Microarray data are deposited at the Genome Expression Omnibus website (GEO, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>) with series number GSE94793. Raw RNA data (CEL files) were preprocessed by Bioconductor and R version 3.2.3. The PIANO package was used for gene ontology (GO) terms and gene set analysis (GSA; V&#x000E4;remo et al., <xref ref-type="bibr" rid="B94">2013</xref>). Only gene sets significantly enriched by distinctly up or down-regulated genes (<italic>p</italic> &#x0003C; 0.05) were considered in this study. The KEGG pathway and Gene Ontology functional categories enrichment analysis were used to investigate the transcriptional regulation of lipogenesis by using online software tool David (Database for Annotation, Visualization, and Integrated Discovery, <ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov">http://david.abcc.ncifcrf.gov</ext-link>; Huang et al., <xref ref-type="bibr" rid="B38">2008</xref>). Adjusted <italic>P</italic> &#x0003C; 0.05 and fold changes &#x0003C;0.81 or &#x0003E;1.2 were used as thresholds to identify significantly differentially expressed genes. Pheatmap package (<ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org/web/packages/pheatmap/index.html">cran.r-project.org/web/packages/pheatmap/index.html</ext-link>) was used to generate clustered heatmaps of gene sets.</p>
</sec>
<sec>
<title>Quantitative real-time PCR (qPCR)</title>
<p>qPCR was performed as previously described (Liu et al., <xref ref-type="bibr" rid="B49">2016</xref>). cDNA was synthesized from 1 &#x003BC;g of total RNA using the QuantiTect Reverse Transcription Kit (QIAGEN, Germany). Two microliters of synthesized cDNA were used as the template for qPCR with the DyNAmo Flash SYBR Green qPCR kit (Thermo Fisher Scientific, USA). Housekeeping gene <italic>ACT1</italic> was used as a reference gene to normalize RNA levels. Used primer sets are listed in Table <xref ref-type="supplementary-material" rid="SM17">S4</xref>.</p>
</sec>
<sec>
<title>Lipid extraction and HPLC-CAD analysis</title>
<p>Lipid extraction and separation were performed as described previously (Khoomrung et al., <xref ref-type="bibr" rid="B45">2013</xref>). Ten micrograms of freeze-dried cells were mixed with 7 ml of chloroform:methanol (2:1, v/v) solution in extraction tubes containing 50 &#x003BC;g of cholesterol as internal standard. Each tube was vigorously vortexed and placed in microwave reaction vessel (12 &#x000D7; 3cm I.D., 0.5 cm thickness, Milestone Stard D, Italy) which was heated to 60&#x000B0;C within 6 min and kept at 60&#x000B0;C for 10 min. After the sample was cooled down to room temperature, 1.7 ml of NaCI was added and the tube was vortexed vigorously. Thereafter, the sample was centrifuged at 1,912 <italic>g</italic> for 10 min and the organic phase was transferred into a clean extraction tube. Organic solvent was evaporated and residues dissolved in 200 &#x003BC;l of chloroform:methanol (2:1, v/v) for HPLC-CAD analysis (Corona, USA). Lipid peaks were identified based on the spectrum of a standard mix (SE, TAG, CH, ES, PA, CL, PE, PC, PS, and PI). Quantification of lipids was performed using serial dilutions of the standard mix from concentrations of 10&#x02013;1,000 &#x003BC;g ml<sup>&#x02212;1</sup>. The average log<sub>10</sub> of peak area was plotted against log<sub>10</sub> of concentration. Correlation (r<sup>2</sup>) was determined for all standard curves by linear regression.</p>
</sec>
<sec>
<title>Statistical analyses</title>
<p>Significance of differences observed in physiological parameters between strains were determined using two-tailed, student <italic>t</italic>-tests. Cultures were independent replicates and, as parameters were determined using identical procedures, student <italic>t</italic>-tests were performed as two-sample with equal variance. Unless specified explicitly, three independent replicate cultures of the A&#x003B2;42 and control strains and two independent replicate cultures of the A&#x003B2;40 strain were analyzed under both fully aerated and micro-aerobic conditions. <italic>P</italic> &#x0003C; 0.05 was considered to indicate significant differences. Values are represented as mean &#x000B1; SEM.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Physiological characterization of humanized yeast A&#x003B2; strains in controlled bioreactor cultures</title>
<p>To determine the effects of human A&#x003B2; peptides on <italic>S. cerevisiae</italic> growth characteristics, strains constitutively expressing either human A&#x003B2;42 or A&#x003B2;40 peptide (hereafter referred to as A&#x003B2;42 and A&#x003B2;40 strain) or carrying the empty vector (control strain) were grown in well-aerated bioreactors using glucose as carbon-source (Figures <xref ref-type="fig" rid="F1">1A,B</xref>). Physiological parameters from these cultures are presented in Table <xref ref-type="table" rid="T1">1</xref>. The maximal specific growth rate of the A&#x003B2;42 strain was 17% lower than that of the control and A&#x003B2;40 strains (<italic>p</italic> &#x0003C; 0.0003), in accordance with our previous report (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>). The A&#x003B2;42 strain also showed a less pronounced but significantly decreased maximal glucose uptake rate (<italic>p</italic> &#x0003D; 0.02), which was reflected by 15% reduced biomass yield during EX (<italic>p</italic> &#x0003C; 0.02). Maximal ethanol production rates were not significantly altered (<italic>p</italic> &#x0003E; 0.4) during EX. On the contrary, we observed substantially increased production of two fermentation products: glycerol and acetate (Table <xref ref-type="table" rid="T1">1</xref>). Glycerol yields were increased in both A&#x003B2; strains (<italic>p</italic> &#x0003C; 0.01), but was highest in the A&#x003B2;42 strain (2.7-fold compared to control strain, <italic>p</italic> &#x0003C; 0.00005). Despite the well-aerated conditions, the A&#x003B2;42 strain also produced more acetate than control and A&#x003B2;40 strains (1.28- and 1.21-fold compared to control and A&#x003B2;40 strains, respectively, <italic>p</italic> &#x0003C; 0.01). Overall these results suggest an altered redox-cofactor balancing in the heterologous A&#x003B2;42 expressing strain (Bakker et al., <xref ref-type="bibr" rid="B5">2001</xref>). During SP, cells rely heavily on the storage carbohydrates glycogen and trehalose as energy sources. No significant differences in the accumulation of glycogen were observed among these strains (Figure <xref ref-type="supplementary-material" rid="SM1">S1A</xref>). Levels of trehalose were significantly higher in the A&#x003B2;42 strain during PD and SP1 (when extracellular carbon source was depleted; Figure <xref ref-type="supplementary-material" rid="SM1">S1B</xref>), which may be linked to its alternative role in stress-resistance. Trehalose can stabilize proteins in their native folding during heat shock and reduce the aggregation of denatured proteins in yeast cells (Singer and Lindquist, <xref ref-type="bibr" rid="B83">1998</xref>). Reduced viable cell fractions might explain reduced growth and substrate consumption rates in the A&#x003B2;42 strain. However, viability analysis showed that fractions of dead cells were low for all strains during different phases (&#x0003C;2.5%). The slightly, yet significantly, elevated fractions of dead cells in A&#x003B2;42 cultures (<italic>p</italic> &#x0003C; 0.007, Figure <xref ref-type="supplementary-material" rid="SM2">S2A</xref>), did not fully explain the observed differences in fermentation kinetics.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>The physiological parameters of all strains during aerobic batch cultivation.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Strain</bold></th>
<th valign="top" align="center"><bold>&#x003BC;<sub>max</sub> <xref ref-type="table-fn" rid="TN2"><sup>a</sup></xref>(/h)</bold></th>
<th valign="top" align="center"><bold>r<sub>glucose,max</sub> <xref ref-type="table-fn" rid="TN3"><sup>b</sup></xref>(g/g/h)</bold></th>
<th valign="top" align="center"><bold>Y<xref ref-type="table-fn" rid="TN4"><sup>c</sup></xref><sub>X/S</sub> (g/g)</bold></th>
<th valign="top" align="center"><bold>Y<xref ref-type="table-fn" rid="TN5"><sup>d</sup></xref><sub>glycerol/S</sub> (mCmol/Cmol)</bold></th>
<th valign="top" align="center"><bold>C<xref ref-type="table-fn" rid="TN6"><sup>e</sup></xref><sub>acetate,max</sub> (mmol/L)</bold></th>
<th valign="top" align="center"><bold>r<xref ref-type="table-fn" rid="TN7"><sup>f</sup></xref><sub>ethanol,max</sub> (g/g/h)</bold></th>
<th valign="top" align="center"><bold>Respiratory quotient<xref ref-type="table-fn" rid="TN8"><sup>g</sup></xref></bold></th>
<th valign="top" align="center"><bold>r<xref ref-type="table-fn" rid="TN9"><sup>h</sup></xref><sub>O2,max</sub> (mmol/g/h)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Control</td>
<td valign="top" align="center">0.368 &#x000B1; 0.002</td>
<td valign="top" align="center">2.34 &#x000B1; 0.05</td>
<td valign="top" align="center">0.39 &#x000B1; 0.01</td>
<td valign="top" align="center">13.5 &#x000B1; 1.5</td>
<td valign="top" align="center">3.6 &#x000B1; 0.2</td>
<td valign="top" align="center">0.24 &#x000B1; 0.02</td>
<td valign="top" align="center">0.42 &#x000B1; 0.01</td>
<td valign="top" align="center">8.2 &#x000B1; 0.5</td>
</tr>
<tr>
<td valign="top" align="left">A&#x003B2;40<xref ref-type="table-fn" rid="TN10"><sup>i</sup></xref></td>
<td valign="top" align="center">0.366 &#x000B1; 0.004</td>
<td valign="top" align="center">2.27 &#x000B1; 0.09</td>
<td valign="top" align="center">0.40 &#x000B1; 0.03</td>
<td valign="top" align="center">20.4<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref> &#x000B1; 0.5</td>
<td valign="top" align="center">3.8 &#x000B1; 0.2</td>
<td valign="top" align="center">0.25 &#x000B1; 0.01</td>
<td valign="top" align="center">0.44 &#x000B1; 0.01</td>
<td valign="top" align="center">7.4 &#x000B1; 0.2</td>
</tr>
<tr>
<td valign="top" align="left">A&#x003B2;42</td>
<td valign="top" align="center">0.304<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref> &#x000B1; 0.003</td>
<td valign="top" align="center">2.18<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref> &#x000B1; 0.05</td>
<td valign="top" align="center">0.36<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref> &#x000B1; 0.01</td>
<td valign="top" align="center">35.3<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref> &#x000B1; 1.4</td>
<td valign="top" align="center">4.6<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref> &#x000B1; 0.1</td>
<td valign="top" align="center">0.22 &#x000B1; 0.01</td>
<td valign="top" align="center">0.40 &#x000B1; 0.02</td>
<td valign="top" align="center">7.5 &#x000B1; 0.2</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Values are represented as the average of three independent biological replicates &#x000B1; SEM. The asterisk (</italic></p>
<fn id="TN1">
<label>&#x0002A;</label>
<p><italic>) indicates significant different values from the control strain parameters (p &#x0003C; 0.05)</italic>.</p></fn>
<fn id="TN2">
<label>a</label>
<p><italic>Maximal biomass-specific growth rate on glucose;</italic></p></fn>
<fn id="TN3">
<label>b</label>
<p><italic>Maximal biomass-specific glucose uptake rate;</italic></p></fn>
<fn id="TN4">
<label>c</label>
<p><italic>Final biomass yields on substrate;</italic></p></fn>
<fn id="TN5">
<label>d</label>
<p><italic>Glycerol yields on glucose;</italic></p></fn>
<fn id="TN6">
<label>e</label>
<p><italic>Maximal acetate concentrations;</italic></p></fn>
<fn id="TN7">
<label>f</label>
<p><italic>Maximal biomass-specific ethanol consumption rate during PD;</italic></p></fn>
<fn id="TN8">
<label>g</label>
<p><italic>Respiratory quotient, the ratio of carbon dioxide produced over oxygen consumed during PD;</italic></p></fn>
<fn id="TN9">
<label>h</label>
<p><italic>Maximal biomass-specific oxygen uptake rate during PD;</italic></p></fn>
<fn id="TN10">
<label>i</label>
<p><italic>Average values from biological duplicates</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>A&#x003B2;42 expression strongly affects mitochondrial functionality</title>
<p>Mitochondria are pivotal to the survival of cells, including neurons, due to their role in energy metabolism. The increased glycerol production in the A&#x003B2;42 strain suggested that the surplus of NADH produced in anabolism, could not be completely reoxidized by mitochondrial respiration (Table <xref ref-type="table" rid="T1">1</xref>). Despite the differences in glycerol and acetate production, the maximal oxygen uptake rates during the fully respiratory PD phase were surprisingly similar for both A&#x003B2; strains, yet lower than control strain (Table <xref ref-type="table" rid="T1">1</xref>). These observations suggested that not consumption of oxygen <italic>per se</italic>, but rather its usage was affected specifically by A&#x003B2;42 expression. Together with our previous observations that the respiratory rate of the A&#x003B2;42 strain was significantly reduced in ethanol-grown cultures (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>), this suggests that the toxicity triggered by A&#x003B2;42 might involve reduced mitochondrial functionality. To further test this, we evaluated the respiratory capacity of all strains during different growth phases. During EX no significant differences were observed between strains, which matched with fermentation being the main catabolic pathway at this phase. However, during the subsequent phases (PD and SP1), the respiratory capacity of the A&#x003B2;42 strain was significantly decreased compared to both other strains (<italic>p</italic> &#x0003C; 0.05, Figure <xref ref-type="fig" rid="F2">2A</xref>). Impaired mitochondrial function can lead to excess reactive oxygen species (ROS) production which contributes to AD pathology (Livnat-Levanon et al., <xref ref-type="bibr" rid="B50">2014</xref>). In the A&#x003B2;42 strain, the ROS-positive fractions were significantly increased during phases of high metabolic activity, i.e., EX and PD, compared to the other strains (<italic>p</italic> &#x0003C; 0.003, Figure <xref ref-type="supplementary-material" rid="SM2">S2B</xref>). To investigate if these physiological indications of mitochondrial dysfunction coincided with aberrant mitochondrial structures, we stained the mitochondria with Rhodamine 123 and employed TPEF (two-photon excited fluorescence) microscopy to investigate the morphology in fully respiratory growing cells. Control cells exhibited continuous mitochondrial structures (networks), whereas A&#x003B2;42 expressing cells displayed a more fragmented structure of mitochondria (Figure <xref ref-type="fig" rid="F2">2C</xref> and Videos <xref ref-type="supplementary-material" rid="SM18">S1</xref>, <xref ref-type="supplementary-material" rid="SM19">S2</xref>). Such fragmented structures of mitochondria were previously observed in aged yeast cells and could enhance the turn-over of damaged mitochondria by mitophagy (Mao and Klionsky, <xref ref-type="bibr" rid="B54">2013</xref>; Breitenbach et al., <xref ref-type="bibr" rid="B10">2014</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>A&#x003B2;42 expression causes abnormal mitochondrial functionality and morphology. <bold>(A)</bold> Respiratory capacity was measured during EX, diauxic shift (DS), PD, early SP (SP1), and late SP (SP2) phases. Measurements were performed in duplicate (A&#x003B2;40) or triplicate (control and A&#x003B2;42) during EX, DS, SP1, and SP2 phases. During PD phase, measurements were done in quadruplicate (A&#x003B2;40 strain) or sextuplicate (control and A&#x003B2;42 strains), when cells solely relied on respiration. <bold>(B)</bold> Comparison of growth rates between aerobic and microaerobic conditions in bioreactors. <bold>(C)</bold> TPEF microscopy images of representative mitochondrial morphology in PD from control and A&#x003B2;42-expressing cells. Mitochondria were stained by Rhodamine 123 and are shown in green. The background fluorescence of cells is shown in red and is indicative of the cell volume. Data shown are average values &#x000B1; SEM, of triplicate (A&#x003B2;42 and control) or duplicate (A&#x003B2;40) independent biological replicates. The asterisk (<sup>&#x0002A;</sup>) indicates significant differences (<italic>p</italic> &#x0003C; 0.05).</p></caption>
<graphic xlink:href="fnmol-10-00232-g0002.tif"/>
</fig>
</sec>
<sec>
<title>Oxygen-limited conditions enhance impact of A&#x003B2;42 expression on physiology</title>
<p>The affected mitochondrial functionality is likely to have a more severe impact on cells under oxygen-limited conditions. Oxygen limitation is common due to increased oxygen-requirements during PD in less-controlled cultivations, such as shake-flasks, in which oxygen-transfer rates are lower (Anderlei and B&#x000FC;chs, <xref ref-type="bibr" rid="B3">2001</xref>). We also noticed this effect by the differences in viability of the same A&#x003B2;42 strain reported here (Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref>) and previously in shake-flasks (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>). In standard bioreactor cultures, the dissolved oxygen levels were maintained above 30% of saturation at all time, but to test the combinatorial effect of oxygen limitation and A&#x003B2; peptides expression on cell physiology, oxygen-limited cultivations were also performed. To this end, the oxygen concentration in the inflowing gas was reduced to 2%, leading to dissolved oxygen levels below 1% of saturation. The reduced dissolved oxygen levels only reduced the maximal growth rate of the A&#x003B2;42 strain on glucose significantly (8% reduction, <italic>p</italic> &#x0003C; 0.05) and did not significantly affect growth of control and A&#x003B2;40 strains (Figure <xref ref-type="fig" rid="F2">2B</xref>). Similarly, total biomass yields were only significantly reduced in the A&#x003B2;42 strain (13% reduction, <italic>p</italic> &#x0003D; 0.05; Table <xref ref-type="supplementary-material" rid="SM14">S1</xref>). Under well-aerated, standard conditions, we observed differences in maximal oxygen uptake rates between A&#x003B2;42 and control strains (Table <xref ref-type="table" rid="T1">1</xref>). When the oxygen supply was severely limited, oxygen uptake rates were also restricted and differences between strains were absent (Table <xref ref-type="supplementary-material" rid="SM14">S1</xref>). However, despite these equal oxygen consumption rates, the A&#x003B2;42 strain produced less carbon dioxide as shown by the almost one-third reduction in respiratory quotient (defined as the ratio of carbon dioxide produced/oxygen consumed) compared to control strain (<italic>p</italic> &#x0003C; 0.05, Table <xref ref-type="supplementary-material" rid="SM14">S1</xref>). This indicates an altered usage of the oxygen consumed by the A&#x003B2;42 strain, likely due to less efficient respiration. In addition to these effects on physiology, oxygen limitation also resulted in a doubling of the fraction of dead cells in all strains (&#x0003C;6%; Figure <xref ref-type="supplementary-material" rid="SM2">S2A</xref>). The ROS-positive fractions were similar compared to well-aerated conditions for all strains during EX and PD, but lower during SP, likely due to reduced oxygen availability (Figure <xref ref-type="supplementary-material" rid="SM2">S2B</xref>).</p>
<p>Oxygen limitation may thus contribute to enhanced cell death, however the drastic effect of A&#x003B2;42 expression on CLS observed in shake-flask cultures (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>) was not observed in oxygen-limited bioreactor cultures. Only 5.25 &#x000B1; 0.44 and 2.39 &#x000B1; 0.64% of cells were identified as dead in A&#x003B2;42 and control cultures, respectively, during SP2, i.e., 2 days after extracellular carbon source exhaustion (Figure <xref ref-type="supplementary-material" rid="SM2">S2A</xref>), in contrast to 37.15 &#x000B1; 1.21 and 14.06 &#x000B1; 1.82%, respectively, in shake-flask cultures (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>). A putative explanation could be the different glucose concentrations in the medium used for bioreactors and shake-flask cultivations, i.e., 10 g L<sup>&#x02212;1</sup> instead of 20 g L<sup>&#x02212;1</sup>, respectively. Shake flask cultures grown in medium containing 10 g L<sup>&#x02212;1</sup> of glucose which is identical to the medium used in bioreactor cultures, revealed indeed a strong effect on viability. The higher initial glucose concentration resulted in a strongly reduced CLS, i.e., the fractions of dead cells were 5&#x02013;7 fold higher during SP2 for the different strains (Figures <xref ref-type="supplementary-material" rid="SM3">S3A,B</xref>). Both initial glucose concentrations are generally not considered to induce calorie restriction related hormesis effects, but strongly affect other culture parameters in stationary phase. When using 10 g L<sup>&#x02212;1</sup> of glucose the pH dropped to only 4.5, instead of to 3.1, when 20 g L<sup>&#x02212;1</sup> of glucose was used (Figures <xref ref-type="supplementary-material" rid="SM3">S3C,D</xref>). Final cell concentrations correlated with initial glucose concentrations (Figures <xref ref-type="supplementary-material" rid="SM3">S3E,F</xref>). The acidic environment poses a strong stress on cells and can result in reduced CLS. An additional confounding factor were higher acetate levels in shake-flask cultures, which were highest for the A&#x003B2;42 strain on 20 g L<sup>&#x02212;1</sup> glucose (Figure <xref ref-type="supplementary-material" rid="SM4">S4</xref>). Altogether oxygen limitation, low pH-values and high acetate concentrations may contribute to the strongly reduced viability and CLS of all strains and especially of the A&#x003B2;42 strain in less-controlled shake-flasks environment. These effects are smaller in bioreactor cultures, because oxygen is not limited and a decrease in pH is prevented by online-monitoring and automated titration of base.</p>
</sec>
<sec>
<title>Global transcriptional response to A&#x003B2; expression</title>
<p>To understand the mechanisms behind the phenotypic changes in A&#x003B2;42 and A&#x003B2;40 strains, gene expression levels during EX, PD, SP1, and SP2 were quantified using microarrays. The global expression pattern was characterized using principal component analysis (PCA). PCA resulted in strong grouping of biological replicates, indicative of a high degree of reproducibility. The first and second PCA components clearly separated all of samples from different growth phases by their gene expression profiles (Figure <xref ref-type="fig" rid="F3">3A</xref> and Figure <xref ref-type="supplementary-material" rid="SM5">S5</xref>). To further examine the extent of changes in each phase, we performed pair-wise comparisons between the strains at each time-point. The expression of 472, 394, 391, and 280 genes was significantly different (adjusted <italic>p</italic> &#x0003C; 0.001) during EX, PD, SP1, and SP2, respectively, between the A&#x003B2;42 strain and the control strain (Figure <xref ref-type="supplementary-material" rid="SM6">S6A</xref>). Although the physiology of the A&#x003B2;40 strain was not notably different from the control strain, expression of 89, 486, and 1,118 genes was significantly different (adjusted <italic>p</italic> &#x0003C; 0.001) during EX, PD, and SP1, respectively. No significantly changed genes were identified later in SP2 between A&#x003B2;40 and control strains (Figure <xref ref-type="supplementary-material" rid="SM6">S6B</xref>). Of note, the overlap in differentially expressed genes was &#x0003C;20% between A&#x003B2;42 and A&#x003B2;40 strains during all phases, suggesting that different biological processes were influenced (Figure <xref ref-type="supplementary-material" rid="SM6">S6C</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Global transcriptional response to A&#x003B2; expression. <bold>(A)</bold> Principle Component Analysis (PCA). Each triangle represents one biological replicate. <bold>(B)</bold> The most strongly enriched GO terms of biological processes in A&#x003B2;42 and A&#x003B2;40 strains, compared to the control strain (<italic>p</italic> &#x0003C; 0.005) during EX, PD, SP1, and SP2, with red color indicating up-regulated processes and blue indicating down-regulated processes. For the complete gene set analysis results, see Figures <xref ref-type="supplementary-material" rid="SM7">S7</xref>, <xref ref-type="supplementary-material" rid="SM8">S8</xref>.</p></caption>
<graphic xlink:href="fnmol-10-00232-g0003.tif"/>
</fig>
<p>To gain more insight in biological processes affected by A&#x003B2;42 and A&#x003B2;40 expression, gene set analysis (GSA) was performed on the significantly differentially expressed genes. Significant enrichment of 126 and 129 gene sets was identified (<italic>p</italic> &#x0003C; 0.005) among genes differentially expressed in A&#x003B2;42 and A&#x003B2;40 strains, respectively compared to the control strain. The complete list of gene sets can be found in Figures <xref ref-type="supplementary-material" rid="SM7">S7</xref>, <xref ref-type="supplementary-material" rid="SM8">S8</xref>. The most significantly enriched gene sets are shown in Figure <xref ref-type="fig" rid="F3">3B</xref> for both A&#x003B2; strains. Gene sets associated with protein processing (post-translational modifications, transport, and degradation), such as, &#x0201C;endoplasmic reticulum (ER),&#x0201D; &#x0201C;protein glycosylation,&#x0201D; &#x0201C;vacuole&#x0201D; were enriched with up-regulated genes during EX, PD, and SP1 in the A&#x003B2;42 strain, but only during EX in the A&#x003B2;40 strain. Gene sets related to protein synthesis such as, &#x0201C;ribosome,&#x0201D; &#x0201C;translation,&#x0201D; &#x0201C;mitochondrial translation,&#x0201D; and &#x0201C;cellular amino acid biosynthetic process,&#x0201D; were enriched with down-regulated genes in the A&#x003B2;42 strain during EX and PD. Remarkably, these genes were up-regulated in the A&#x003B2;42 strain compared to the control strain during SP. The expression profiles of these protein synthesis related genes were studied throughout the different culture phases. This revealed that for genes, whose expression was higher in the A&#x003B2;42 strain than control strain in SP, this was due to a less pronounced decrease in expression (data not shown). These protein synthesis-related gene sets were enriched with up-regulated genes in the A&#x003B2;40 strain especially in PD. This opposite regulation of these genes clearly indicated different responses to A&#x003B2;42 and A&#x003B2;40 expression. For illustration, the genes involved in amino acid biosynthesis pathways of which expression levels were significantly changed can be found in Figure <xref ref-type="supplementary-material" rid="SM9">S9</xref> and Table <xref ref-type="supplementary-material" rid="SM15">S2</xref>. In addition to these processes directly involved in protein synthesis and processing, transcription related gene sets such as, &#x0201C;nucleic acid binding,&#x0201D; &#x0201C;protein import into nucleus,&#x0201D; &#x0201C;ribonucleoprotein complex,&#x0201D; and &#x0201C;mRNA transport&#x0201D; were enriched with down-regulated genes in both A&#x003B2; strains.</p>
</sec>
<sec>
<title>A&#x003B2;42 expression induces strong ER stress response</title>
<p>As a key component of cellular proteostasis, the ER is responsible for processing of one-third of cellular proteins and harbors an elaborate protein quality control system (PQC) to eliminate misfolded proteins by degradation (Cao and Kaufman, <xref ref-type="bibr" rid="B14">2012</xref>). However, an overload of the PQC machinery results in an ER stress response (ESR) and activates the unfolded protein response (UPR; Scheper and Hoozemans, <xref ref-type="bibr" rid="B77">2015</xref>). In the A&#x003B2;42 strain, most genes involved in &#x0201C;response to stress&#x0201D; were significantly higher expressed, including <italic>HAC1</italic>, the key regulator of UPR. In response to ER stress, <italic>HAC1</italic> (<italic>HAC1</italic><sup><italic>u</italic></sup>) mRNA is spliced to <italic>HAC1</italic> (<italic>HAC1</italic><sup><italic>s</italic></sup>) to initiate synthesis of the active transcription activator Hac1p which induces expression of over 300 of UPR target genes (Travers et al., <xref ref-type="bibr" rid="B91">2000</xref>). The ratio of <italic>HAC1</italic><sup><italic>s</italic></sup>/<italic>HAC1</italic><sup><italic>u</italic></sup> was 19, 17, and 13-fold higher in the A&#x003B2;42 strain compared to the control strain during EX, PD, and SP1, respectively (Figure <xref ref-type="supplementary-material" rid="SM10">S10A</xref>). Induction of UPR target genes results in the biosynthesis of chaperones, and other factors involved in the secretory pathway, and ER associated degradation (ERAD) to restore ER homeostasis. The gene sets related to protein processing were strongly triggered upon expression of A&#x003B2;42 (Figure <xref ref-type="fig" rid="F4">4</xref>). Genes encoding &#x0201C;folding&#x0201D; chaperones such as, <italic>KAR2, SIL1, SCJ1, JEM1</italic>, and disulfide bond formation enzymes <italic>PDI1</italic> and <italic>ERO1</italic> were indeed all found significantly up-regulated (Figure <xref ref-type="fig" rid="F4">4</xref>). Higher transcription levels of <italic>PDI1</italic> and <italic>ERO1</italic> were verified by qPCR (Figures <xref ref-type="supplementary-material" rid="SM10">S10B,C</xref>). Genes encoding proteins involved in processes throughout the secretory pathway including translocation, glycosylation, GPI (Glycosylphosphatidylinositol) biosynthesis, trafficking between ER and Golgi, ER associated degradation (ERAD), and vacuole were also significantly higher expressed in the A&#x003B2;42 strain (Figure <xref ref-type="fig" rid="F4">4</xref>). Besides ERAD, which is the predominant cellular mechanism to degrade misfolded proteins under ER stress, autophagy can also be activated when the amount of misfolded proteins exceeds the ER capacity (Bernales et al., <xref ref-type="bibr" rid="B7">2006</xref>). In line with this, the A&#x003B2;42 strain expressed the autophagy related genes <italic>ATG8, ATG22, ATG34, NVJ1</italic>, and <italic>ATG19</italic> to a higher extent (Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Transcriptional profiles of differentially expressed genes encoding proteins involved in protein secretory and metabolic processes in the A&#x003B2;42 strain. Changes in gene expression are shown as fold changes compared to the control strain during EX, PD, SP1, and SP2.</p></caption>
<graphic xlink:href="fnmol-10-00232-g0004.tif"/>
</fig>
<p>In the A&#x003B2;40 strain, changes in expression levels of genes involved in protein processing were less pronounced (Figure <xref ref-type="supplementary-material" rid="SM11">S11</xref>). The ratio of <italic>HAC1</italic><sup><italic>s</italic></sup>/<italic>HAC1</italic><sup><italic>u</italic></sup> in the A&#x003B2;40 strain was only 5.8-fold higher than control strain in EX. qPCR confirmed that transcript levels of <italic>PDI1</italic> and <italic>ERO1</italic> were not significantly changed (Figure <xref ref-type="supplementary-material" rid="SM10">S10</xref>). The distributions of significantly differentially expressed genes between A&#x003B2;42 and A&#x003B2;40 strains are shown in Figure <xref ref-type="supplementary-material" rid="SM12">S12</xref> (<italic>p</italic> &#x0003C; 0.05). All differentially expressed genes involved in protein processing are listed in Table <xref ref-type="supplementary-material" rid="SM16">S3</xref>.</p>
</sec>
<sec>
<title>A&#x003B2;42 expression increases lipid synthesis</title>
<p>It was previously shown that ER stress and activation of UPR pathways play a critical role in lipid metabolism in different model organisms (Hetz, <xref ref-type="bibr" rid="B33">2012</xref>). GSA revealed that the gene sets related to &#x0201C;lipid metabolic process&#x0201D; were overrepresented with up-regulated genes in both A&#x003B2; strains during EX. More specifically, gene sets involved in &#x0201C;glycerolipid biosynthesis process,&#x0201D; &#x0201C;phospholipid biosynthetic process,&#x0201D; &#x0201C;glycerophospholipid biosynthetic process,&#x0201D; and &#x0201C;lipid biosynthetic process&#x0201D; were strongly overrepresented among up-regulated genes in the A&#x003B2;42 strain during EX, compared to the control strain. Similar results were also found for the A&#x003B2;40 strain. However, for the A&#x003B2;40 strain, the enrichment was less strong and the amounts of significantly up-regulated genes involved in each processes were, respectively, 30, 34, 31, and 42% lower than for the A&#x003B2;42 strain (Figure <xref ref-type="fig" rid="F5">5A</xref>). The expression level of <italic>INO1</italic>, the gene encoding an important regulator in lipid metabolism in yeast (Henry et al., <xref ref-type="bibr" rid="B31">2012</xref>), was significantly increased in the A&#x003B2;42 strain during EX (data not shown). To see whether the different expression patterns led to alterations in cellular lipid composition, we measured different lipid classes dynamically in all three strains. The major lipid constituents of <italic>S. cerevisiae</italic>: storage lipids, phospholipids, and sterols were analyzed. Compared to the control strain, the levels of all lipid categories were significantly increased during EX and PD in the A&#x003B2;42 strain. The differences were most pronounced during EX. In the A&#x003B2;40 strain, only phospholipids showed a slight but significant increase during EX and PD compared to control strain (Figure <xref ref-type="fig" rid="F5">5B</xref>). To gain insight in the structural storage of lipids we monitored the three-dimensional distribution and amounts of lipids stored at the single-cell level (which usually coalesce into lipid droplets) by CARS (coherent anti-Stokes Raman scattering) microscopy in exponentially growing cells. CARS can probe and image lipid structures by vibrations between carbon and hydrogen bonds and hence no fluorescent labels or tags are needed. The average lipid droplet volume was 1.6-fold larger in the A&#x003B2;42 strain (0.078 &#x000B1; 0.032 &#x003BC;m<sup>3</sup>) than in the control strain (0.048 &#x000B1; 0.028 &#x003BC;m<sup>3</sup>; Figure <xref ref-type="supplementary-material" rid="SM13">S13</xref>). CARS images showed that the lipid droplets in control cells were numerous and smaller in sizes, whereas they tended to accumulate and form larger drops in A&#x003B2;42 expressing cells (Figure <xref ref-type="fig" rid="F5">5C</xref> and Videos <xref ref-type="supplementary-material" rid="SM20">S3</xref>, <xref ref-type="supplementary-material" rid="SM21">S4</xref>).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>A&#x003B2;42 expression results in increased lipid synthesis. <bold>(A)</bold> For significantly enriched GO terms involved in lipid biosynthetic processes, the percentages of genes that are either higher (red), lower (blue), or not significantly (NS, gray) differentially expressed in both A&#x003B2; strains during EX, PD, and SP1 are shown. <bold>(B)</bold> Cellular concentrations of storage lipids, phospholipids and ergosterol were measured by HPLC-CAD in all strains. TAG, Triacylglycerols; SE, steryl esters; PA, phosphatidic acid; PI, phosphatidylinositol; PS, phosphatidylserine; PC, phosphatidylcholine; PE, phosphatidylethanolamine; ES, sterol ergosterol. <bold>(C)</bold> CARS microscopy visualization of lipid droplets (in yellow) during EX in control and A&#x003B2;42-expressing cells. The background fluorescence of cells is shown in red and is indicative of the cell volume.</p></caption>
<graphic xlink:href="fnmol-10-00232-g0005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Humanized yeast models have been exploited to investigate protein functions and cellular pathways implicated in neurodegenerative disorders including Huntington&#x00027;s disease (Giorgini et al., <xref ref-type="bibr" rid="B27">2005</xref>), Parkinson&#x00027;s disease (Outeiro and Lindquist, <xref ref-type="bibr" rid="B66">2003</xref>), and AD (Zhang et al., <xref ref-type="bibr" rid="B105">1994</xref>). To study the cytotoxicity of A&#x003B2; peptides in AD, several yeast models have been explored (Verduyckt et al., <xref ref-type="bibr" rid="B95">2016</xref>), of which only recent models recapitulate important aspects of A&#x003B2; cytotoxicity by including intracellular trafficking (Treusch et al., <xref ref-type="bibr" rid="B92">2011</xref>; D&#x00027;Angelo et al., <xref ref-type="bibr" rid="B20">2013</xref>). To overcome a major disadvantage of these models, i.e., the use of inducible promoters resulting in strong acute cytotoxicity, we recently presented an improved yeast model in which human A&#x003B2; peptides are constitutively expressed, only moderately affecting growth. To our knowledge all studies with these and similar models have been carried out in uncontrolled cultivation systems, such as, shake-flask, tubes, or 96-well plates due to their ease and scalability. However, these cultures present a highly dynamic environment, with changes in nutrient and metabolite levels, pH, and oxygen availability (B&#x000FC;chs, <xref ref-type="bibr" rid="B11">2001</xref>), that strongly influence the growth of Crabtree-positive <italic>S. cerevisiae</italic>. In contrast, the stable (controlled) environments in bioreactor cultures are well defined and highly reproducible. In this paper, we dynamically elucidate the effects of different human A&#x003B2; peptides expression on yeast physiology and transcriptome by using bioreactor cultures. This allowed partial confirmation of earlier observation on the role of A&#x003B2; peptides in AD pathology (Treusch et al., <xref ref-type="bibr" rid="B92">2011</xref>; Nair et al., <xref ref-type="bibr" rid="B62">2014</xref>; Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>), but also revealed remarkable differences and increased our knowledge on the mechanistic principles behind cytotoxicity of different A&#x003B2; peptides.</p>
<p>Both shake-flask and bioreactor cultures displayed a reduction in the maximal growth rate of the A&#x003B2;42 strain (Chen and Petranovic, <xref ref-type="bibr" rid="B16">2015</xref>). However, the previously observed drastic effect on CLS was significantly reduced in bioreactor cultures, which underlines the importance of culture conditions in aging and aging-related disease models (Longo et al., <xref ref-type="bibr" rid="B44">2012</xref>). There may be several reasons for the observed difference in CLS between the two experimental set-ups. First and likely foremost, the well-controlled environment reduced additional stresses on cells. As illustrated by the comparison of aerobic and micro-aerobic conditions in bioreactor cultures, sufficient availability of oxygen had a beneficial effect on CLS (Figure <xref ref-type="supplementary-material" rid="SM2">S2A</xref>). An additional important parameter kept constant in bioreactor cultures was pH. Neuronal excitability is highly susceptible to fluctuations of intracellular and extracellular pH (Ruffin et al., <xref ref-type="bibr" rid="B74">2014</xref>). One of the main clinical presentations of AD includes signs of decreased brain pH (Demetrius and Simon, <xref ref-type="bibr" rid="B22">2012</xref>). The combination of low pH and presence of toxic peptides might contribute to neuronal cell death. As we confirmed in our yeast model, in non-pH-controlled shake-flask cultures, the acidity of medium increases due to both ammonium consumption and the production of acids, such as acetic acid and CO<sub>2</sub> (Fraenkel, <xref ref-type="bibr" rid="B25">1982</xref>; Burtner et al., <xref ref-type="bibr" rid="B12">2009</xref>). The degree of acidification depends on medium composition and strain. In our study, an increase in initial glucose concentration from 10 to 20 g L<sup>&#x02212;1</sup> resulted in a more than 10-fold increase in proton concentration (Figures <xref ref-type="supplementary-material" rid="SM3">S3C,D</xref>). Virtually all cellular processes are dependent on intracellular pH (Orij et al., <xref ref-type="bibr" rid="B65">2012</xref>), for example acidification of the cytosol is an early event to regulate caspase-dependent apoptosis in yeast (Matsuyama et al., <xref ref-type="bibr" rid="B56">2000</xref>), and collapse of intracellular pH homeostasis shifts the model of cell death from apoptosis to necrosis in <italic>Caenorhabditis elegans</italic> (Syntichaki et al., <xref ref-type="bibr" rid="B87">2005</xref>). Depending on the extracellular pH, cells invest significant amounts of energy to keep intracellular pH homeostasis to maintain viability (Della-Bianca et al., <xref ref-type="bibr" rid="B21">2014</xref>). Increased energy expenditure in acidified non-controlled cultures negatively influences viability, as other studies showed that CLS can be enhanced by buffering the culture pH (Fabrizio et al., <xref ref-type="bibr" rid="B24">2004</xref>). And these effects might be even stronger in already challenged A&#x003B2;42 expressing cells. In addition to contributing to low pH, organic acids have been shown to affect cell performance in specific manners (Abbott et al., <xref ref-type="bibr" rid="B1">2007</xref>). Especially acetic acid is a potent cell-stressor that has been shown to induce lysosomal apoptotic pathway either in a mitochondria-independent or dependent way (Marques et al., <xref ref-type="bibr" rid="B55">2013</xref>; Oliveira et al., <xref ref-type="bibr" rid="B64">2015</xref>). Under bioreactor conditions less acetate was produced by all strains than in shake-flask cultures (Figure <xref ref-type="supplementary-material" rid="SM4">S4</xref> and Table <xref ref-type="table" rid="T1">1</xref>). Higher initial glucose concentrations also led to higher acetate levels, especially for the A&#x003B2;42 strain. Overall the reduced oxygen availability, low pH, and increased acetate levels cause additional stress and strongly affect survival of A&#x003B2;42 expressing cells.</p>
<p>Human brain activity corresponds to a high fraction of total energy consumption, and neurons strongly depend on mitochondria due to a limited glycolytic capacity (Moreira et al., <xref ref-type="bibr" rid="B59">2009</xref>). Mitochondrial dysfunction leads to energy metabolism abnormalities that endanger normal neuron functioning and contribute to AD pathology. In yeast expressing A&#x003B2;42, lower growth rates and reduced biomass yields were observed (Table <xref ref-type="table" rid="T1">1</xref>). This reflects a redirection of energy from growth to maintenance, i.e., processes aimed at maintaining cell integrity and functioning that do not lead to an increase in biomass. In addition, it also points at reduced ATP generation from the energy sources consumed as indicated by reduced oxygen consumption rates and lower respiratory quotient (Figure <xref ref-type="fig" rid="F2">2A</xref> and Table <xref ref-type="supplementary-material" rid="SM14">S1</xref>). Reduced energy metabolism in the diseased brain is one of best documented abnormalities in AD (Moreira et al., <xref ref-type="bibr" rid="B60">2007</xref>). In fact, the low glucose baseline metabolism and its decline during aging are viewed as sensitive measures and being increasingly adopted to assist diagnosis in cognitive decline (Shokouhi et al., <xref ref-type="bibr" rid="B81">2013</xref>; Yamane et al., <xref ref-type="bibr" rid="B102">2014</xref>). Several groups reported that A&#x003B2; peptides accumulate in mitochondria and directly interact with several mitochondrial proteins (Manczak et al., <xref ref-type="bibr" rid="B53">2006</xref>; Pagani and Eckert, <xref ref-type="bibr" rid="B67">2011</xref>; Pavlov et al., <xref ref-type="bibr" rid="B70">2011</xref>). The interaction of A&#x003B2; peptides with A&#x003B2;-binding alcohol dehydrogenase (ABAD) in mitochondria promotes leakage of ROS, mitochondrial dysfunction and cell death in AD patients and transgenic mice (Lustbader et al., <xref ref-type="bibr" rid="B52">2004</xref>). The interaction of A&#x003B2; peptides with mitochondria appears to affect a multitude of different functions in AD, including respiration, detoxification of ROS, and organellar morphology (Rhein et al., <xref ref-type="bibr" rid="B72">2009</xref>; Yao et al., <xref ref-type="bibr" rid="B103">2009</xref>; Selfridge et al., <xref ref-type="bibr" rid="B78">2013</xref>). Here, we observed similar responses specifically in yeast cells expressing the more toxic A&#x003B2;42 peptide. With TPEF microscopy, aberrant fragmented mitochondrial structures were detected in the A&#x003B2;42 strain. In brain tissue from AD patients and neuronal cells expressing mutant APP, similar fragmented mitochondria and structural changes have been observed (Hirai et al., <xref ref-type="bibr" rid="B34">2001</xref>; Wang et al., <xref ref-type="bibr" rid="B99">2008</xref>).</p>
<p>Genome wide expression level analysis revealed that both A&#x003B2; peptides expression induced ESR, although the A&#x003B2;40 strain did not show significant physiological changes (Figure <xref ref-type="fig" rid="F3">3B</xref>). Studies proposed an important role for ER stress in AD pathogenesis by acting as a mediator of A&#x003B2; neurotoxicity (Umeda et al., <xref ref-type="bibr" rid="B93">2011</xref>; Hoozemans et al., <xref ref-type="bibr" rid="B37">2012</xref>). A&#x003B2; furthermore triggers ER stress-specific apoptosis through caspase-12 and caspase-4 (Nakagawa et al., <xref ref-type="bibr" rid="B63">2000</xref>; Hitomi et al., <xref ref-type="bibr" rid="B35">2004</xref>). ER stress results in activation of UPR, one of stress response pathways, which aims to restore ER homeostasis (Cao and Kaufman, <xref ref-type="bibr" rid="B14">2012</xref>). In yeast, the UPR is regulated solely by the Ire1 pathway which is conserved from yeast to mammals (Iwawaki et al., <xref ref-type="bibr" rid="B39">2001</xref>). In response to ER stress, activated Ire1p splices <italic>HAC1</italic><sup><italic>u</italic></sup> to <italic>HAC1</italic><sup><italic>s</italic></sup> to initiate synthesis of Hac1p which translocates into nucleus to regulate expression of UPR target genes (Mori et al., <xref ref-type="bibr" rid="B61">2000</xref>). The different ratio of <italic>HAC1</italic><sup><italic>s</italic></sup>/<italic>HAC1</italic><sup><italic>u</italic></sup> in A&#x003B2;42 and A&#x003B2;40 strains suggested that the expression of these variants results in a different extent of ER stress and consequently UPR. This is in accordance with previous findings in yeast, which show that UPR signaling can be modulated through differential target gene expression depending on the nature of stress (Thibault et al., <xref ref-type="bibr" rid="B89">2011</xref>). The different nature of the two A&#x003B2; peptides investigated here, showed that A&#x003B2;40 triggered a mild response, and A&#x003B2;42 resulted in a stronger stress affecting many aspects of the physiology of the cells. Decreasing the ER protein load is the first attempt of UPR to restore proteostasis. In our study, the processes involved in protein folding/maturation, ER-to-Golgi trafficking and ERAD were significantly upregulated in both A&#x003B2; strains initiating from EX, though at different levels. In addition to ERAD, autophagy was activated only in the A&#x003B2;42 strain, which suggested that the amounts of misfolded or aggregated proteins exceed the ER capacity (Figure <xref ref-type="fig" rid="F4">4</xref>). Global transcription, translation, and amino acid synthesis were repressed in response to A&#x003B2;42 expression (Figure <xref ref-type="fig" rid="F3">3B</xref> and Figure <xref ref-type="supplementary-material" rid="SM7">S7</xref>). By these responses, the influx of new proteins into ER can be reduced, whereas the efflux is increased. The large fraction of nuclear-DNA encoded mitochondrial proteins is processed through the ER. Reduced mitochondrial protein biogenesis and turn-over can result in increased dysfunction, thereby linking the UPR with energy metabolism. Mitochondria furthermore communicate directly with ER through MAM (mitochondria-associated ER membranes) to regulate several fundamental cellular processes (Csord&#x000E1;s et al., <xref ref-type="bibr" rid="B18">2006</xref>; Rowland and Voeltz, <xref ref-type="bibr" rid="B73">2012</xref>). This crosstalk between ER and mitochondria may have a role in facilitating stress response and UPR (Bernales et al., <xref ref-type="bibr" rid="B8">2012</xref>; Stoica et al., <xref ref-type="bibr" rid="B85">2014</xref>; Paillusson et al., <xref ref-type="bibr" rid="B68">2016</xref>). However, these processes were up-regulated in the A&#x003B2;40 strain during PD, which suggested the cells started to re-establish homeostasis within the ER (Figure <xref ref-type="fig" rid="F3">3B</xref> and Figure <xref ref-type="supplementary-material" rid="SM8">S8</xref>). When the buffering capacity of UPR proves inadequate to restore ER proteostasis, the pathway switches from an adaptation program to apoptosis to remove irreversibly damaged cells (Rutkowski et al., <xref ref-type="bibr" rid="B75">2006</xref>; Szegezdi et al., <xref ref-type="bibr" rid="B88">2006</xref>). This is reflected by the significantly elevated fractions of dead cells in A&#x003B2;42 strain cultures, compared to cultures of control and A&#x003B2;40 strains (Figure <xref ref-type="supplementary-material" rid="SM2">S2A</xref>).</p>
<p>Recently, it was found that ER stress and UPR activation regulate cellular processes beyond ER protein folding and play crucial roles in lipid metabolism by controlling the transcriptional regulation of lipogenesis in the liver (Lee et al., <xref ref-type="bibr" rid="B48">2008</xref>; Zhang et al., <xref ref-type="bibr" rid="B106">2011</xref>). We found that at the transcript level, genes involved in lipid biosynthesis were higher expressed in both A&#x003B2; strains compared to the control strain during EX (Figure <xref ref-type="fig" rid="F5">5A</xref>). UPR regulates inositol, an important regulator of lipid metabolism in yeast, which plays a key role in phospholipid biosynthesis required for membranes (Jesch et al., <xref ref-type="bibr" rid="B42">2005</xref>). The expression levels of <italic>INO1</italic>, the gene encoding the enzyme that catalyzes the rate-limiting step in <italic>de novo</italic> synthesis of inositol (Henry et al., <xref ref-type="bibr" rid="B31">2012</xref>), was significantly increased in the A&#x003B2;42 strain during EX. Moreover, the tight link between lipid synthesis and UPR was shown previously by the induction of UPR upon <italic>OPI3</italic> or <italic>INO1</italic> deletion (Jonikas et al., <xref ref-type="bibr" rid="B43">2009</xref>). We used lipidomics to quantify the lipid and sterol components and it showed a significant increase in phospholipids and storage lipids during growth phases in the A&#x003B2;42 strain (Figure <xref ref-type="fig" rid="F5">5B</xref>). This result was further supported by CARS microscopy, which showed significantly larger lipid drops in the A&#x003B2;42 strain compared to the control strain during EX (Figure <xref ref-type="fig" rid="F5">5C</xref>). Links between lipid metabolism and AD have been previously proposed, since the initial observation that feeding rabbits with a cholesterol-enriched diet leads to A&#x003B2; accumulation (Sparks et al., <xref ref-type="bibr" rid="B84">1994</xref>). Nowadays several studies provide substantial evidence that aberrant lipid metabolism is closely connected to A&#x003B2; modulation during the pathogenesis of AD in humans (Wood, <xref ref-type="bibr" rid="B100">2012</xref>; Walter and van Echten-Deckert, <xref ref-type="bibr" rid="B98">2013</xref>). Apolipoprotein E (ApoE) is the strongest known genetic risk factor for the most common late-onset sporadic AD (Corder et al., <xref ref-type="bibr" rid="B17">1993</xref>; Strittmatter et al., <xref ref-type="bibr" rid="B86">1993</xref>), which might impair A&#x003B2; clearance and increase its aggregation in the brain (Bales et al., <xref ref-type="bibr" rid="B6">1997</xref>; Holtzman et al., <xref ref-type="bibr" rid="B36">2000</xref>; Verghese et al., <xref ref-type="bibr" rid="B96">2013</xref>). Moreover, alterations in membrane lipid composition, including cholesterol and sphingolipids may also affect A&#x003B2; generation and aggregation properties (Simons et al., <xref ref-type="bibr" rid="B82">1998</xref>; Sawamura et al., <xref ref-type="bibr" rid="B76">2004</xref>). Conversely, A&#x003B2; can influence lipid homeostasis by modulating lipid metabolic enzymes and directly binding to membrane lipids (Cutler et al., <xref ref-type="bibr" rid="B19">2004</xref>; Grimm et al., <xref ref-type="bibr" rid="B29">2005</xref>). Our study demonstrated that A&#x003B2;-induced ER stress might be an additional mechanism contributing to the increased brain cholesterol content observed in AD.</p>
<p>Overall, this study provided highly informative data regarding changes in cellular metabolic activity and energy metabolism as consequences of different A&#x003B2; peptides expression. The expression of A&#x003B2;40 and A&#x003B2;42 peptides also caused different levels of ER stress which tightly regulates the amplitude and kinetics of UPR signaling to decide different cell fates (Figure <xref ref-type="fig" rid="F6">6</xref>). Due to the emerging role of UPR in diverse disease conditions, such as, cancer, diabetes, and neurodegeneration, understanding how the UPR interacts with other cellular regulations is fundamental for the identification of future points of intervention in many important and to date often incurable human diseases.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Schematic overview of the effects of constitutive expression of A&#x003B2;40 or A&#x003B2;42 peptides. A&#x003B2;40 and A&#x003B2;42 differ in potential to form aggregates resulting in different levels of ER stress and induction of the unfolded protein response (UPR). Constitutive expression of A&#x003B2;40, induces mild ER stress and subsequent activation of the UPR recovers proteome homeostasis (proteostasis) by promoting protein (re)folding, protein quality control, and degradation mechanisms. A&#x003B2;42 peptides, on the contrary, result in prolonged ER stress and the strongly activated UPR fails to buffer the misfolded protein load, leading to cellular dysfunction and a shorter chronological life span (CLS). ERAD, ER-associated degradation; ROS, reactive oxygen species; Green mitochondria, functional; Red mitochondria, dysfunctional; Light blue ER, mild ER stress; Dark blue ER, strong ER stress; Yellow, lipid droplets.</p></caption>
<graphic xlink:href="fnmol-10-00232-g0006.tif"/>
</fig>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>XC, MB, and DP designed research; XC and MB performed and analyzed batch cultivation, extracellular metabolites, mitochondrial bioenergetics, molecular, and cellular experiments. NA performed Non-linear microscopy experiments. KS prepared cells for Non-linear microscopy experiments. XC, MB, and BJ analyzed microarray data. XC, MB, and DP wrote the manuscript, with contributions from NA and BJ.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack><p>DP would like to dedicate the paper to the memory of Prof. Susan Lindquist, a dear friend, mentor, and colleague whose work on humanized yeast models and proteostasis continues to inspire us. XC and MB are grateful to Dr. Mingtao Huang, Dr. Zhiwei Zhu, and Dr. Leif V&#x000E4;remo for valuable discussions and comments on the manuscript. NA is grateful to Prof. Annika Enejder for providing the non-linear microscopy lab. We thank the Bioinformatics and Expression Analysis core facility (BEA) at the Karolinska Institute for help with microarray.</p>
</ack>
<sec sec-type="supplementary-material" id="s6">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fnmol.2017.00232/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fnmol.2017.00232/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S1</label>
<caption><p>Cellular reserve carbohydrate concentrations in batch cultures. Cellular contents of glycogen <bold>(A)</bold> and trehalose <bold>(B)</bold> are measured during PD, SP1, and SP2 phases under aerobic condition. Results represent average values &#x000B1; SEM, of triplicate (A&#x003B2;42 and control) or duplicate (A&#x003B2;40) independent biological replicates. The asterisk (<sup>&#x0002A;</sup>) indicates significant differences (<italic>p</italic> &#x0003C; 0.001).</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM2" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S2</label>
<caption><p>Fractions of dead cells and reactive oxygen species (ROS) positive cells as function of age in aerobic and microaerobic cultures. <bold>(A)</bold> Cells were stained with PI and analyzed by flow cytometry, PI-positive cells are considered dead. <bold>(B)</bold> Cells were stained with DHR123 and analyzed by flow cytometry. Strongly fluorescent cells (i.e., 5&#x02013;100 times more fluorescent than low fluorescent cells) are considered ROS positive. Insert shows the values for the first three growth phases in detail. Full lines and dotted lines indicate aerobic or microaerobic conditions, respectively.</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM3" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S3</label>
<caption><p>Comparison of fractions of dead cells <bold>(A,B)</bold>, pH <bold>(C,D)</bold>, and cell growth <bold>(E,F)</bold> between 1 and 2% glucose cultures grown in shake flasks.</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM4" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S4</label>
<caption><p>Quantification and comparison of acetate production under different culture conditions after glucose exhaustion (diauxic shift, DS).</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM5" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S5</label>
<caption><p>Principle Component Analysis (PCA). Histogram of variance for each PC shows that the first two PCs capture the largest variance of dataset, which are 70% (PC1) and 19.8% (PC2), respectively.</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM6" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S6</label>
<caption><p>The Venn diagrams show distribution of significantly differentially expressed genes between A&#x003B2;42 and control strains <bold>(A)</bold>, A&#x003B2;40 and control strains <bold>(B)</bold>, A&#x003B2;42 and A&#x003B2;40 strains <bold>(C)</bold> during different growth phases (<italic>p</italic> &#x0003C; 0.001).</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM7" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S7</label>
<caption><p>The significantly enriched GO terms in A&#x003B2;42 strain among genes differentially expressed compared to control strain (<italic>p</italic> &#x0003C; 0.001).</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM8" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S8</label>
<caption><p>The significantly enriched GO terms in A&#x003B2;40 strain among genes differentially expressed compared to control strain (<italic>p</italic> &#x0003C; 0.001).</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM9" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S9</label>
<caption><p>Schematic overview of significantly changed genes in amino acid biosynthetic pathways in A&#x003B2;42 strain <bold>(A)</bold> and A&#x003B2;40 strain <bold>(B)</bold> compared to control strain. Differences in gene expression levels are shown as fold changes compared to control strain during EX, PD, SP1, and SP2 phases (<italic>p</italic> &#x0003C; 0.05).</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM10" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S10</label>
<caption><p>qPCR analysis of <italic>HAC1</italic><sup><italic>s</italic></sup>/<italic>HAC1</italic><sup><italic>u</italic></sup> ratio <bold>(A)</bold>, <italic>PDI1</italic> <bold>(B)</bold>, and <italic>ERO1</italic> <bold>(C)</bold> mRNA levels in all strains from EX, PD, and SP1 phases. Results are average values &#x000B1; SEM, of triplicate (A&#x003B2;42 and control) or duplicate (A&#x003B2;40) independent biological replicates. The asterisk (<sup>&#x0002A;</sup>) indicates significant differences (<italic>p</italic> &#x0003C; 0.05).</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM11" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S11</label>
<caption><p>Transcriptional profiles of differentially expressed genes related to protein secretory and metabolic processes in A&#x003B2;40 strain compared to control strain. Changes in gene expressions are shown as fold changes compared to control strain during EX, PD, SP1, and SP2.</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM12" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S12</label>
<caption><p>The Venn diagrams show distribution of significantly differentially expressed genes in protein secretory and metabolic processes between A&#x003B2;42 and A&#x003B2;40 strains during EX <bold>(A)</bold>, PD <bold>(B)</bold>, and SP1 <bold>(C)</bold> phases (<italic>p</italic> &#x0003C; 0.05).</p></caption></supplementary-material>
<supplementary-material xlink:href="Image1.pdf" id="SM13" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Figure S13</label>
<caption><p>Quantitative analysis of CARS microscopy images presenting the contents of lipids in control and A&#x003B2;42 expressing cells during EX. Ten images were analyzed for each strain. Each image contains one or more cells. The value of lipid content was calculated by the ratio of summation over stacks of lipids area/summation over stacks of cell area. The average lipid content was higher in A&#x003B2;42 strain (0.078 &#x000B1; 0.032 &#x003BC;m<sup>3</sup>) than in control strain (0.048 &#x000B1; 0.028 &#x003BC;m<sup>3</sup>).</p></caption></supplementary-material>
<supplementary-material xlink:href="Table1.pdf" id="SM14" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Table S1</label>
<caption><p>Physiological parameters of micro-aerobic batch cultures.</p></caption></supplementary-material>
<supplementary-material xlink:href="Table2.xlsx" id="SM15" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Table S2</label>
<caption><p>Genes with significantly different expression in amino acid biosynthetic pathways (A&#x003B2;42 strain vs. control strain).</p></caption></supplementary-material>
<supplementary-material xlink:href="Table3.xlsx" id="SM16" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Table S3</label>
<caption><p>Genes with significantly different expression in protein secretory and metabolic processes (A&#x003B2;40 strain vs. control strain).</p></caption></supplementary-material>
<supplementary-material xlink:href="Table4.pdf" id="SM17" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Table S4</label>
<caption><p>Primer-sets used for qPCR.</p></caption></supplementary-material>
<supplementary-material xlink:href="Video1.MP4" id="SM18" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Video S1</label>
<caption><p>3D movie of a representative image of mitochondrial structure in control cell. Mitochondria were stained with Rhodamine 123 and shown in green. Red shows the background of TPEF microscopy and is indicative of cell volume.</p></caption></supplementary-material>
<supplementary-material xlink:href="Video2.MP4" id="SM19" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Video S2</label>
<caption><p>3D movie of a representative image of mitochondrial structure in A&#x003B2;42-expressing cells. Mitochondria were stained with Rhodamine 123 and shown in green. Red shows the background of TPEF microscopy and is indicative of cell volume.</p></caption></supplementary-material>
<supplementary-material xlink:href="Video3.MP4" id="SM20" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Video S3</label>
<caption><p>3D movie of a representative image of lipid drops in control cell. Yellow, lipid drops; red, background of CARS microscopy to indicate the cell volume.</p></caption></supplementary-material>
<supplementary-material xlink:href="Video4.MP4" id="SM21" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Video S4</label>
<caption><p>3D movie of a representative images of lipid drops in A&#x003B2;42-expressing cells. Yellow, lipid drops; red, background of CARS microscopy to indicate the cell volume.</p></caption></supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname> <given-names>D. A.</given-names></name> <name><surname>Knijnenburg</surname> <given-names>T. A.</given-names></name> <name><surname>De Poorter</surname> <given-names>L. M. I.</given-names></name> <name><surname>Reinders</surname> <given-names>M. J. T.</given-names></name> <name><surname>Pronk</surname> <given-names>J. T.</given-names></name> <name><surname>van Maris</surname> <given-names>A. J. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Generic and specific transcriptional responses to different weak organic acids in anaerobic chemostat cultures of <italic>Saccharomyces cerevisiae</italic></article-title>. <source>FEMS Yeast Res.</source> <volume>7</volume>, <fpage>819</fpage>&#x02013;<lpage>833</lpage>. <pub-id pub-id-type="doi">10.1111/j.1567-1364.2007.00242.x</pub-id><pub-id pub-id-type="pmid">17484738</pub-id></citation>
</ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albers</surname> <given-names>E.</given-names></name> <name><surname>Larsson</surname> <given-names>C.</given-names></name> <name><surname>Andlid</surname> <given-names>T.</given-names></name> <name><surname>Walsh</surname> <given-names>M. C.</given-names></name> <name><surname>Gustafsson</surname> <given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Effect of nutrient starvation on the cellular composition and metabolic capacity of <italic>Saccharomyces cerevisiae</italic></article-title>. <source>Appl. Environ. Microbiol.</source> <volume>73</volume>, <fpage>4839</fpage>&#x02013;<lpage>4848</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00425-07</pub-id><pub-id pub-id-type="pmid">17545328</pub-id></citation>
</ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderlei</surname> <given-names>T.</given-names></name> <name><surname>B&#x000FC;chs</surname> <given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Device for sterile online measurement of the oxygen transfer rate in shaking flasks</article-title>. <source>Biochem. Eng. J.</source> <volume>7</volume>, <fpage>157</fpage>&#x02013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/S1369-703X(00)00116-9</pub-id><pub-id pub-id-type="pmid">11173305</pub-id></citation>
</ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagriantsev</surname> <given-names>S.</given-names></name> <name><surname>Liebman</surname> <given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Modulation of Abeta42 low-n oligomerization using a novel yeast reporter system</article-title>. <source>BMC Biol.</source> <volume>4</volume>:<fpage>32</fpage>. <pub-id pub-id-type="doi">10.1186/1741-7007-4-32</pub-id><pub-id pub-id-type="pmid">17002801</pub-id></citation>
</ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname> <given-names>B. M.</given-names></name> <name><surname>Overkamp</surname> <given-names>K. M.</given-names></name> <name><surname>van Maris</surname> <given-names>A. J. A.</given-names></name> <name><surname>K&#x000F6;tter</surname> <given-names>P.</given-names></name> <name><surname>Luttik</surname> <given-names>M. A. H.</given-names></name> <name><surname>Pronk</surname> <given-names>J. T.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>Stoichiometry and compartmentation of NADH metabolism in <italic>Saccharomyces cerevisiae</italic></article-title>. <source>FEMS Microbiol. Rev.</source> <volume>25</volume>, <fpage>15</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6976.2001.tb00570.x</pub-id><pub-id pub-id-type="pmid">11152939</pub-id></citation>
</ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bales</surname> <given-names>K. R.</given-names></name> <name><surname>Verina</surname> <given-names>T.</given-names></name> <name><surname>Dodel</surname> <given-names>R. C.</given-names></name> <name><surname>Du</surname> <given-names>Y.</given-names></name> <name><surname>Altstiel</surname> <given-names>L.</given-names></name> <name><surname>Bender</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>1997</year>). <article-title>Lack of apolipoprotein E dramatically reduces amyloid [&#x003B2;]-peptide deposition</article-title>. <source>Nat. Genet.</source> <volume>17</volume>, <fpage>263</fpage>&#x02013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1038/ng1197-263</pub-id><pub-id pub-id-type="pmid">9354781</pub-id></citation>
</ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernales</surname> <given-names>S.</given-names></name> <name><surname>McDonald</surname> <given-names>K. L.</given-names></name> <name><surname>Walter</surname> <given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response</article-title>. <source>PLoS Biol.</source> <volume>4</volume>:<fpage>e423</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.0040423</pub-id><pub-id pub-id-type="pmid">17132049</pub-id></citation>
</ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernales</surname> <given-names>S.</given-names></name> <name><surname>Morales Soto</surname> <given-names>M.</given-names></name> <name><surname>McCullagh</surname> <given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegeneration</article-title>. <source>Front. Aging Neurosci.</source> <volume>4</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2012.00005</pub-id><pub-id pub-id-type="pmid">22539924</pub-id></citation>
</ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bisschops</surname> <given-names>M. M. M.</given-names></name> <name><surname>Vos</surname> <given-names>T.</given-names></name> <name><surname>Moreno-Martinez</surname> <given-names>R.</given-names></name> <name><surname>De La Torre-Cortes</surname> <given-names>P.</given-names></name> <name><surname>Pronk</surname> <given-names>J. T.</given-names></name> <name><surname>Daran-Lapujade</surname> <given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Oxygen availability strongly affects chronological lifespan and thermotolerance in batch cultures of <italic>Saccharomyces cerevisiae</italic></article-title>. <source>Microb. Cell</source> <volume>2</volume>, <fpage>429</fpage>&#x02013;<lpage>444</lpage>. <pub-id pub-id-type="doi">10.15698/mic2015.11.238</pub-id><pub-id pub-id-type="pmid">28357268</pub-id></citation>
</ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breitenbach</surname> <given-names>M.</given-names></name> <name><surname>Rinnerthaler</surname> <given-names>M.</given-names></name> <name><surname>Hartl</surname> <given-names>J.</given-names></name> <name><surname>Stincone</surname> <given-names>A.</given-names></name> <name><surname>Vowinckel</surname> <given-names>J.</given-names></name> <name><surname>Breitenbach-Koller</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Mitochondria in ageing: there is metabolism beyond the ROS</article-title>. <source>FEMS Yeast Res.</source> <volume>14</volume>, <fpage>198</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1111/1567-1364.12134</pub-id><pub-id pub-id-type="pmid">24373480</pub-id></citation>
</ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>B&#x000FC;chs</surname> <given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Introduction to advantages and problems of shaken cultures</article-title>. <source>Biochem. Eng. J.</source> <volume>7</volume>, <fpage>91</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/S1369-703X(00)00106-6</pub-id><pub-id pub-id-type="pmid">11173295</pub-id></citation>
</ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burtner</surname> <given-names>C. R.</given-names></name> <name><surname>Murakami</surname> <given-names>C. J.</given-names></name> <name><surname>Kennedy</surname> <given-names>B. K.</given-names></name> <name><surname>Kaeberlein</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>A molecular mechanism of chronological aging in yeast</article-title>. <source>Cell Cycle</source> <volume>8</volume>, <fpage>1256</fpage>&#x02013;<lpage>1270</lpage>. <pub-id pub-id-type="doi">10.4161/cc.8.8.8287</pub-id><pub-id pub-id-type="pmid">19305133</pub-id></citation>
</ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burtner</surname> <given-names>C. R.</given-names></name> <name><surname>Murakami</surname> <given-names>C. J.</given-names></name> <name><surname>Olsen</surname> <given-names>B.</given-names></name> <name><surname>Kennedy</surname> <given-names>B. K.</given-names></name> <name><surname>Kaeberlein</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>A genomic analysis of chronological longevity factors in budding yeast</article-title>. <source>Cell Cycle</source> <volume>10</volume>, <fpage>1385</fpage>&#x02013;<lpage>1396</lpage>. <pub-id pub-id-type="doi">10.4161/cc.10.9.15464</pub-id><pub-id pub-id-type="pmid">21447998</pub-id></citation>
</ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>S. S.</given-names></name> <name><surname>Kaufman</surname> <given-names>R. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Unfolded protein response</article-title>. <source>Curr. Biol.</source> <volume>22</volume>, <fpage>R622</fpage>&#x02013;<lpage>R626</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2012.07.004</pub-id><pub-id pub-id-type="pmid">22917505</pub-id></citation>
</ref>
<ref id="B15">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Castrillo</surname> <given-names>J. I.</given-names></name> <name><surname>Oliver</surname> <given-names>S. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Systems biology of multifactorial diseases: Alzheimer&#x00027;s disease</article-title>, in <source>Systems Biology of Alzheimer&#x00027;s Disease</source>, eds <person-group person-group-type="editor"><name><surname>Castrillo</surname> <given-names>J. I.</given-names></name> <name><surname>Oliver</surname> <given-names>S. G.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Humana Press</publisher-name>), <fpage>3</fpage>&#x02013;<lpage>48</lpage>.</citation>
</ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Petranovic</surname> <given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Amyloid-&#x003B2; peptide-induced cytotoxicity and mitochondrial dysfunction in yeast</article-title>. <source>FEMS Yeast Res.</source> <volume>15</volume>:<fpage>fov061</fpage>. <pub-id pub-id-type="doi">10.1093/femsyr/fov061</pub-id><pub-id pub-id-type="pmid">26152713</pub-id></citation>
</ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corder</surname> <given-names>E.</given-names></name> <name><surname>Saunders</surname> <given-names>A.</given-names></name> <name><surname>Strittmatter</surname> <given-names>W.</given-names></name> <name><surname>Schmechel</surname> <given-names>D.</given-names></name> <name><surname>Gaskell</surname> <given-names>P.</given-names></name> <name><surname>Small</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>1993</year>). <article-title>Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&#x00027;s disease in late onset families</article-title>. <source>Science</source> <volume>261</volume>, <fpage>921</fpage>&#x02013;<lpage>923</lpage>. <pub-id pub-id-type="doi">10.1126/science.8346443</pub-id><pub-id pub-id-type="pmid">8346443</pub-id></citation>
</ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Csord&#x000E1;s</surname> <given-names>G.</given-names></name> <name><surname>Renken</surname> <given-names>C.</given-names></name> <name><surname>V&#x000E1;rnai</surname> <given-names>P.</given-names></name> <name><surname>Walter</surname> <given-names>L.</given-names></name> <name><surname>Weaver</surname> <given-names>D.</given-names></name> <name><surname>Buttle</surname> <given-names>K. F.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Structural and functional features and significance of the physical linkage between ER and mitochondria</article-title>. <source>J. Cell Biol.</source> <volume>174</volume>, <fpage>915</fpage>&#x02013;<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200604016</pub-id><pub-id pub-id-type="pmid">16982799</pub-id></citation>
</ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname> <given-names>R. G.</given-names></name> <name><surname>Kelly</surname> <given-names>J.</given-names></name> <name><surname>Storie</surname> <given-names>K.</given-names></name> <name><surname>Pedersen</surname> <given-names>W. A.</given-names></name> <name><surname>Tammara</surname> <given-names>A.</given-names></name> <name><surname>Hatanpaa</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer&#x00027;s disease</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>101</volume>, <fpage>2070</fpage>&#x02013;<lpage>2075</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0305799101</pub-id><pub-id pub-id-type="pmid">14970312</pub-id></citation>
</ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x00027;Angelo</surname> <given-names>F.</given-names></name> <name><surname>Vignaud</surname> <given-names>H.</given-names></name> <name><surname>Di Martino</surname> <given-names>J.</given-names></name> <name><surname>Salin</surname> <given-names>B.</given-names></name> <name><surname>Devin</surname> <given-names>A.</given-names></name> <name><surname>Cullin</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>A yeast model for amyloid-&#x003B2; aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity</article-title>. <source>Dis. Model. Mech.</source> <volume>6</volume>, <fpage>206</fpage>&#x02013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.010108</pub-id><pub-id pub-id-type="pmid">22888099</pub-id></citation>
</ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Della-Bianca</surname> <given-names>B. E.</given-names></name> <name><surname>De Hulster</surname> <given-names>E.</given-names></name> <name><surname>Pronk</surname> <given-names>J. T.</given-names></name> <name><surname>van Maris</surname> <given-names>A. J.</given-names></name> <name><surname>Gombert</surname> <given-names>A. K.</given-names></name></person-group> (<year>2014</year>). <article-title>Physiology of the fuel ethanol strain <italic>Saccharomyces cerevisiae</italic> PE-2 at low pH indicates a context-dependent performance relevant for industrial applications</article-title>. <source>FEMS Yeast Res.</source> <volume>14</volume>, <fpage>1196</fpage>&#x02013;<lpage>1205</lpage>. <pub-id pub-id-type="doi">10.1111/1567-1364.12217</pub-id><pub-id pub-id-type="pmid">25263709</pub-id></citation>
</ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demetrius</surname> <given-names>L. A.</given-names></name> <name><surname>Simon</surname> <given-names>D. K.</given-names></name></person-group> (<year>2012</year>). <article-title>An inverse-Warburg effect and the origin of Alzheimer&#x00027;s disease</article-title>. <source>Biogerontology</source> <volume>13</volume>, <fpage>583</fpage>&#x02013;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-012-9403-6</pub-id><pub-id pub-id-type="pmid">23086530</pub-id></citation>
</ref>
<ref id="B23">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Entian</surname> <given-names>K.-D.</given-names></name> <name><surname>K&#x000F6;tter</surname> <given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>25 yeast genetic strain and plasmid collections</article-title>, in <source>Methods in Microbiology</source>, eds <person-group person-group-type="editor"><name><surname>Ian</surname> <given-names>S.</given-names></name> <name><surname>Michael</surname> <given-names>J. R. S.</given-names></name></person-group> (<publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>Academic Press</publisher-name>), <fpage>629</fpage>&#x02013;<lpage>666</lpage>.</citation>
</ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fabrizio</surname> <given-names>P.</given-names></name> <name><surname>Battistella</surname> <given-names>L.</given-names></name> <name><surname>Vardavas</surname> <given-names>R.</given-names></name> <name><surname>Gattazzo</surname> <given-names>C.</given-names></name> <name><surname>Liou</surname> <given-names>L.-L.</given-names></name> <name><surname>Diaspro</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Superoxide is a mediator of an altruistic aging program in <italic>Saccharomyces cerevisiae</italic></article-title>. <source>J. Cell Biol.</source> <volume>166</volume>, <fpage>1055</fpage>&#x02013;<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200404002</pub-id><pub-id pub-id-type="pmid">15452146</pub-id></citation>
</ref>
<ref id="B25">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Fraenkel</surname> <given-names>D.</given-names></name></person-group> (<year>1982</year>). <source>Carbohydrate Metabolism.</source> <publisher-loc>Cold Spring Harbor, CA</publisher-loc>: <publisher-name>Cold Spring Harbor Press</publisher-name>.</citation>
</ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fruhmann</surname> <given-names>G.</given-names></name> <name><surname>Seynnaeve</surname> <given-names>D.</given-names></name> <name><surname>Zheng</surname> <given-names>J.</given-names></name> <name><surname>Ven</surname> <given-names>K.</given-names></name> <name><surname>Molenberghs</surname> <given-names>S.</given-names></name> <name><surname>Wilms</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Yeast buddies helping to unravel the complexity of neurodegenerative disorders</article-title>. <source>Mech. Ageing Dev.</source> <volume>161</volume>, <fpage>288</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2016.05.002</pub-id><pub-id pub-id-type="pmid">27181083</pub-id></citation>
</ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giorgini</surname> <given-names>F.</given-names></name> <name><surname>Guidetti</surname> <given-names>P.</given-names></name> <name><surname>Nguyen</surname> <given-names>Q.</given-names></name> <name><surname>Bennett</surname> <given-names>S. C.</given-names></name> <name><surname>Muchowski</surname> <given-names>P. J.</given-names></name></person-group> (<year>2005</year>). <article-title>A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington&#x00027;s disease</article-title>. <source>Nat. Genet.</source> <volume>37</volume>, <fpage>526</fpage>&#x02013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1038/ng1542</pub-id></citation>
</ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gouras</surname> <given-names>G. K.</given-names></name> <name><surname>Almeida</surname> <given-names>C. G.</given-names></name> <name><surname>Takahashi</surname> <given-names>R. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Intraneuronal A&#x003B2; accumulation and origin of plaques in Alzheimer&#x00027;s disease</article-title>. <source>Neurobiol. Aging</source> <volume>26</volume>, <fpage>1235</fpage>&#x02013;<lpage>1244</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.05.022</pub-id><pub-id pub-id-type="pmid">16023263</pub-id></citation>
</ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grimm</surname> <given-names>M. O. W.</given-names></name> <name><surname>Grimm</surname> <given-names>H. S.</given-names></name> <name><surname>Patzold</surname> <given-names>A. J.</given-names></name> <name><surname>Zinser</surname> <given-names>E. G.</given-names></name> <name><surname>Halonen</surname> <given-names>R.</given-names></name> <name><surname>Duering</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Regulation of cholesterol and sphingomyelin metabolism by amyloid-[&#x003B2;] and presenilin</article-title>. <source>Nat. Cell Biol.</source> <volume>7</volume>, <fpage>1118</fpage>&#x02013;<lpage>1123</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1313</pub-id><pub-id pub-id-type="pmid">16227967</pub-id></citation>
</ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname> <given-names>J.</given-names></name> <name><surname>Selkoe</surname> <given-names>D. J.</given-names></name></person-group> (<year>2002</year>). <article-title>The amyloid hypothesis of Alzheimer&#x00027;s disease: progress and problems on the road to therapeutics</article-title>. <source>Science</source> <volume>297</volume>, <fpage>353</fpage>&#x02013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1126/science.1072994</pub-id><pub-id pub-id-type="pmid">12130773</pub-id></citation>
</ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname> <given-names>S. A.</given-names></name> <name><surname>Kohlwein</surname> <given-names>S. D.</given-names></name> <name><surname>Carman</surname> <given-names>G. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Metabolism and regulation of glycerolipids in the yeast <italic>Saccharomyces cerevisiae</italic></article-title>. <source>Genetics</source> <volume>190</volume>, <fpage>317</fpage>&#x02013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.111.130286</pub-id><pub-id pub-id-type="pmid">22345606</pub-id></citation>
</ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname> <given-names>P. K.</given-names></name></person-group> (<year>2002</year>). <article-title>Stationary phase in yeast</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>5</volume>, <fpage>602</fpage>&#x02013;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1016/S1369-5274(02)00377-6</pub-id><pub-id pub-id-type="pmid">12457705</pub-id></citation>
</ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hetz</surname> <given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>The unfolded protein response: controlling cell fate decisions under ER stress and beyond</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>13</volume>, <fpage>89</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3270</pub-id><pub-id pub-id-type="pmid">22251901</pub-id></citation>
</ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname> <given-names>K.</given-names></name> <name><surname>Aliev</surname> <given-names>G.</given-names></name> <name><surname>Nunomura</surname> <given-names>A.</given-names></name> <name><surname>Fujioka</surname> <given-names>H.</given-names></name> <name><surname>Russell</surname> <given-names>R. L.</given-names></name> <name><surname>Atwood</surname> <given-names>C. S.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>Mitochondrial abnormalities in Alzheimer&#x00027;s disease</article-title>. <source>J. Neurosci.</source> <volume>21</volume>, <fpage>3017</fpage>&#x02013;<lpage>3023</lpage>. <pub-id pub-id-type="pmid">11312286</pub-id></citation>
</ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hitomi</surname> <given-names>J.</given-names></name> <name><surname>Katayama</surname> <given-names>T.</given-names></name> <name><surname>Eguchi</surname> <given-names>Y.</given-names></name> <name><surname>Kudo</surname> <given-names>T.</given-names></name> <name><surname>Taniguchi</surname> <given-names>M.</given-names></name> <name><surname>Koyama</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and A&#x003B2;-induced cell death</article-title>. <source>J. Cell Biol.</source> <volume>165</volume>, <fpage>347</fpage>&#x02013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200310015</pub-id><pub-id pub-id-type="pmid">15123740</pub-id></citation>
</ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holtzman</surname> <given-names>D. M.</given-names></name> <name><surname>Bales</surname> <given-names>K. R.</given-names></name> <name><surname>Tenkova</surname> <given-names>T.</given-names></name> <name><surname>Fagan</surname> <given-names>A. M.</given-names></name> <name><surname>Parsadanian</surname> <given-names>M.</given-names></name> <name><surname>Sartorius</surname> <given-names>L. J.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer&#x00027;s disease</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>97</volume>, <fpage>2892</fpage>&#x02013;<lpage>2897</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.050004797</pub-id><pub-id pub-id-type="pmid">10694577</pub-id></citation>
</ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoozemans</surname> <given-names>J. J. M.</given-names></name> <name><surname>Van Haastert</surname> <given-names>E. S.</given-names></name> <name><surname>Nijholt</surname> <given-names>D. A. T.</given-names></name> <name><surname>Rozemuller</surname> <given-names>A. J. M.</given-names></name> <name><surname>Scheper</surname> <given-names>W.</given-names></name></person-group> (<year>2012</year>). <article-title>Activation of the unfolded protein response is an early event in Alzheimer&#x00027;s and Parkinson&#x00027;s disease</article-title>. <source>Neurodegenerative Dis.</source> <volume>10</volume>, <fpage>212</fpage>&#x02013;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1159/000334536</pub-id><pub-id pub-id-type="pmid">22302012</pub-id></citation>
</ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>D. W.</given-names></name> <name><surname>Sherman</surname> <given-names>B. T.</given-names></name> <name><surname>Lempicki</surname> <given-names>R. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat. Protoc.</source> <volume>4</volume>, <fpage>44</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id></citation>
</ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iwawaki</surname> <given-names>T.</given-names></name> <name><surname>Hosoda</surname> <given-names>A.</given-names></name> <name><surname>Okuda</surname> <given-names>T.</given-names></name> <name><surname>Kamigori</surname> <given-names>Y.</given-names></name> <name><surname>Nomura-Furuwatari</surname> <given-names>C.</given-names></name> <name><surname>Kimata</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress</article-title>. <source>Nat. Cell Biol.</source> <volume>3</volume>, <fpage>158</fpage>&#x02013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1038/35055065</pub-id><pub-id pub-id-type="pmid">11175748</pub-id></citation>
</ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jarrett</surname> <given-names>J. T.</given-names></name> <name><surname>Berger</surname> <given-names>E. P.</given-names></name> <name><surname>Lansbury</surname> <given-names>P. T.</given-names></name></person-group> (<year>1993</year>). <article-title>The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer&#x00027;s disease</article-title>. <source>Biochemistry</source> <volume>32</volume>, <fpage>4693</fpage>&#x02013;<lpage>4697</lpage>. <pub-id pub-id-type="doi">10.1021/bi00069a001</pub-id><pub-id pub-id-type="pmid">8490014</pub-id></citation>
</ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>N. B.</given-names></name> <name><surname>Strucko</surname> <given-names>T.</given-names></name> <name><surname>Kildegaard</surname> <given-names>K. R.</given-names></name> <name><surname>David</surname> <given-names>F.</given-names></name> <name><surname>Maury</surname> <given-names>J.</given-names></name> <name><surname>Mortensen</surname> <given-names>U. H.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>EasyClone: method for iterative chromosomal integration of multiple genes in <italic>Saccharomyces cerevisiae</italic></article-title>. <source>FEMS Yeast Res.</source> <volume>14</volume>, <fpage>238</fpage>&#x02013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1111/1567-1364.12118</pub-id><pub-id pub-id-type="pmid">24151867</pub-id></citation>
</ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jesch</surname> <given-names>S. A.</given-names></name> <name><surname>Zhao</surname> <given-names>X.</given-names></name> <name><surname>Wells</surname> <given-names>M. T.</given-names></name> <name><surname>Henry</surname> <given-names>S. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Genome-wide analysis reveals inositol, not choline, as the major effector of Ino2p-Ino4p and unfolded protein response target gene expression in yeast</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume>, <fpage>9106</fpage>&#x02013;<lpage>9118</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M411770200</pub-id></citation>
</ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jonikas</surname> <given-names>M. C.</given-names></name> <name><surname>Collins</surname> <given-names>S. R.</given-names></name> <name><surname>Denic</surname> <given-names>V.</given-names></name> <name><surname>Oh</surname> <given-names>E.</given-names></name> <name><surname>Quan</surname> <given-names>E. M.</given-names></name> <name><surname>Schmid</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum</article-title>. <source>Science</source> <volume>323</volume>, <fpage>1693</fpage>&#x02013;<lpage>1697</lpage>. <pub-id pub-id-type="doi">10.1126/science.1167983</pub-id><pub-id pub-id-type="pmid">19325107</pub-id></citation>
</ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname> <given-names>V. D.</given-names></name> <name><surname>Shadel</surname> <given-names>G. S.</given-names></name> <name><surname>Kaeberlein</surname> <given-names>M.</given-names></name> <name><surname>Kennedy</surname> <given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Replicative and chronological aging in <italic>Saccharomyces cerevisiae</italic></article-title>. <source>Cell Metab.</source> <volume>16</volume>, <fpage>18</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2012.06.002</pub-id><pub-id pub-id-type="pmid">22768836</pub-id></citation>
</ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khoomrung</surname> <given-names>S.</given-names></name> <name><surname>Chumnanpuen</surname> <given-names>P.</given-names></name> <name><surname>Jansa-Ard</surname> <given-names>S.</given-names></name> <name><surname>St&#x000E5;hlman</surname> <given-names>M.</given-names></name> <name><surname>Nookaew</surname> <given-names>I.</given-names></name> <name><surname>Bor&#x000E9;n</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Rapid quantification of yeast lipid using microwave-assisted total lipid extraction and HPLC-CAD</article-title>. <source>Anal. Chem.</source> <volume>85</volume>, <fpage>4912</fpage>&#x02013;<lpage>4919</lpage>. <pub-id pub-id-type="doi">10.1021/ac3032405</pub-id><pub-id pub-id-type="pmid">23634639</pub-id></citation>
</ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khurana</surname> <given-names>V.</given-names></name> <name><surname>Lindquist</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Modelling neurodegeneration in <italic>Saccharomyces cerevisiae</italic>: why cook with baker&#x00027;s yeast?</article-title> <source>Nat. Rev. Neurosci.</source> <volume>11</volume>, <fpage>436</fpage>&#x02013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2809</pub-id><pub-id pub-id-type="pmid">20424620</pub-id></citation>
</ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kl&#x000F6;ckner</surname> <given-names>W.</given-names></name> <name><surname>B&#x000FC;chs</surname> <given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Advances in shaking technologies</article-title>. <source>Trends Biotechnol.</source> <volume>30</volume>, <fpage>307</fpage>&#x02013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2012.03.001</pub-id><pub-id pub-id-type="pmid">22520242</pub-id></citation>
</ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>A.-H.</given-names></name> <name><surname>Scapa</surname> <given-names>E. F.</given-names></name> <name><surname>Cohen</surname> <given-names>D. E.</given-names></name> <name><surname>Glimcher</surname> <given-names>L. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Regulation of hepatic lipogenesis by the transcription factor XBP1</article-title>. <source>Science</source> <volume>320</volume>, <fpage>1492</fpage>&#x02013;<lpage>1496</lpage>. <pub-id pub-id-type="doi">10.1126/science.1158042</pub-id><pub-id pub-id-type="pmid">18556558</pub-id></citation>
</ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>G.</given-names></name> <name><surname>Bergenholm</surname> <given-names>D.</given-names></name> <name><surname>Nielsen</surname> <given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Genome-wide mapping of binding sites reveals multiple biological functions of the transcription factor Cst6p in <italic>Saccharomyces cerevisiae</italic></article-title>. <source>MBio</source> <volume>7</volume>:<fpage>e00559</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.00559-16</pub-id><pub-id pub-id-type="pmid">27143390</pub-id></citation>
</ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livnat-Levanon</surname> <given-names>N.</given-names></name> <name><surname>Kevei</surname> <given-names>E.</given-names></name> <name><surname>Kleifeld</surname> <given-names>O.</given-names></name> <name><surname>Krutauz</surname> <given-names>D.</given-names></name> <name><surname>Segref</surname> <given-names>A.</given-names></name> <name><surname>Rinaldi</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Reversible 26S proteasome disassembly upon mitochondrial stress</article-title>. <source>Cell Rep.</source> <volume>7</volume>, <fpage>1371</fpage>&#x02013;<lpage>1380</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.04.030</pub-id><pub-id pub-id-type="pmid">24857655</pub-id></citation>
</ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luheshi</surname> <given-names>L. M.</given-names></name> <name><surname>Tartaglia</surname> <given-names>G. G.</given-names></name> <name><surname>Brorsson</surname> <given-names>A. C.</given-names></name> <name><surname>Pawar</surname> <given-names>A. P.</given-names></name> <name><surname>Watson</surname> <given-names>I. E.</given-names></name> <name><surname>Chiti</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Systematic <italic>in vivo</italic> analysis of the intrinsic determinants of amyloid &#x003B2; pathogenicity</article-title>. <source>PLoS Biol.</source> <volume>5</volume>:<fpage>e290</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.0050290</pub-id><pub-id pub-id-type="pmid">17973577</pub-id></citation>
</ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lustbader</surname> <given-names>J. W.</given-names></name> <name><surname>Cirilli</surname> <given-names>M.</given-names></name> <name><surname>Lin</surname> <given-names>C.</given-names></name> <name><surname>Xu</surname> <given-names>H. W.</given-names></name> <name><surname>Takuma</surname> <given-names>K.</given-names></name> <name><surname>Wang</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>ABAD directly links A&#x000DF; to mitochondrial toxicity in Alzheimer&#x00027;s disease</article-title>. <source>Science</source> <volume>304</volume>, <fpage>448</fpage>&#x02013;<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1126/science.1091230</pub-id></citation>
</ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manczak</surname> <given-names>M.</given-names></name> <name><surname>Anekonda</surname> <given-names>T. S.</given-names></name> <name><surname>Henson</surname> <given-names>E.</given-names></name> <name><surname>Park</surname> <given-names>B. S.</given-names></name> <name><surname>Quinn</surname> <given-names>J.</given-names></name> <name><surname>Reddy</surname> <given-names>P. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondria are a direct site of A&#x003B2; accumulation in Alzheimer&#x00027;s disease neurons: implications for free radical generation and oxidative damage in disease progression</article-title>. <source>Hum. Mol. Genet.</source> <volume>15</volume>, <fpage>1437</fpage>&#x02013;<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddl066</pub-id></citation>
</ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname> <given-names>K.</given-names></name> <name><surname>Klionsky</surname> <given-names>D. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Participation of mitochondrial fission during mitophagy</article-title>. <source>Cell Cycle</source> <volume>12</volume>, <fpage>3131</fpage>&#x02013;<lpage>3132</lpage>. <pub-id pub-id-type="doi">10.4161/cc.26352</pub-id><pub-id pub-id-type="pmid">24013417</pub-id></citation>
</ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname> <given-names>C.</given-names></name> <name><surname>Oliveira</surname> <given-names>C. S. F.</given-names></name> <name><surname>Alves</surname> <given-names>S.</given-names></name> <name><surname>Chaves</surname> <given-names>S. R.</given-names></name> <name><surname>Coutinho</surname> <given-names>O. P.</given-names></name> <name><surname>Corte-Real</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release</article-title>. <source>Cell Death Dis.</source> <volume>4</volume>, <fpage>e507</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2013.29</pub-id><pub-id pub-id-type="pmid">23429293</pub-id></citation>
</ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuyama</surname> <given-names>S.</given-names></name> <name><surname>Llopis</surname> <given-names>J.</given-names></name> <name><surname>Deveraux</surname> <given-names>Q. L.</given-names></name> <name><surname>Tsien</surname> <given-names>R. Y.</given-names></name> <name><surname>Reed</surname> <given-names>J. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis</article-title>. <source>Nat. Cell Biol.</source> <volume>2</volume>, <fpage>318</fpage>&#x02013;<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1038/35014006</pub-id><pub-id pub-id-type="pmid">10854321</pub-id></citation>
</ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname> <given-names>C. A.</given-names></name> <name><surname>Cherny</surname> <given-names>R. A.</given-names></name> <name><surname>Fraser</surname> <given-names>F. W.</given-names></name> <name><surname>Fuller</surname> <given-names>S. J.</given-names></name> <name><surname>Smith</surname> <given-names>M. J.</given-names></name> <name><surname>Konrad</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>1999</year>). <article-title>Soluble pool of A&#x003B2; amyloid as a determinant of severity of neurodegeneration in Alzheimer&#x00027;s disease</article-title>. <source>Ann. Neurol.</source> <volume>46</volume>, <fpage>860</fpage>&#x02013;<lpage>866</lpage>. <pub-id pub-id-type="doi">10.1002/1531-8249(199912)46:6&#x0003C;860::AID-ANA8&#x0003E;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">10589538</pub-id></citation>
</ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mertz</surname> <given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Nonlinear microscopy: new techniques and applications</article-title>. <source>Curr. Opin. Neurobiol.</source> <volume>14</volume>, <fpage>610</fpage>&#x02013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2004.08.013</pub-id><pub-id pub-id-type="pmid">15464895</pub-id></citation>
</ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname> <given-names>P. I.</given-names></name> <name><surname>Duarte</surname> <given-names>A. I.</given-names></name> <name><surname>Santos</surname> <given-names>M. S.</given-names></name> <name><surname>Rego</surname> <given-names>A. C.</given-names></name> <name><surname>Oliveira</surname> <given-names>C. R.</given-names></name></person-group> (<year>2009</year>). <article-title>An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer&#x00027;s disease</article-title>. <source>J. Alzheimers Dis.</source> <volume>16</volume>, <fpage>741</fpage>&#x02013;<lpage>761</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2009-0972</pub-id><pub-id pub-id-type="pmid">19387110</pub-id></citation>
</ref>
<ref id="B60">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Moreira</surname> <given-names>P. I.</given-names></name> <name><surname>Nunomura</surname> <given-names>A.</given-names></name> <name><surname>Honda</surname> <given-names>K.</given-names></name> <name><surname>Aliev</surname> <given-names>G.</given-names></name> <name><surname>Casadesus</surname> <given-names>G.</given-names></name> <name><surname>Zhu</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>The key role of oxidative stress in Alzheimer&#x00027;s disease</article-title>, in <source>Oxidative Stress and Neurodegenerative Disorders</source>, ed <person-group person-group-type="editor"><name><surname>Parvez</surname> <given-names>S. H.</given-names></name></person-group> (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier Science B.V.</publisher-name>), <fpage>267</fpage>&#x02013;<lpage>281</lpage>.</citation>
</ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname> <given-names>K.</given-names></name> <name><surname>Ogawa</surname> <given-names>N.</given-names></name> <name><surname>Kawahara</surname> <given-names>T.</given-names></name> <name><surname>Yanagi</surname> <given-names>H.</given-names></name> <name><surname>Yura</surname> <given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>mRNA splicing-mediated C-terminal replacement of transcription factor Hac1p is required for efficient activation of the unfolded protein response</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>97</volume>, <fpage>4660</fpage>&#x02013;<lpage>4665</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.050010197</pub-id><pub-id pub-id-type="pmid">10781071</pub-id></citation>
</ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname> <given-names>S.</given-names></name> <name><surname>Traini</surname> <given-names>M.</given-names></name> <name><surname>Dawes</surname> <given-names>I. W.</given-names></name> <name><surname>Perrone</surname> <given-names>G. G.</given-names></name></person-group> (<year>2014</year>). <article-title>Genome-wide analysis of <italic>Saccharomyces cerevisiae</italic> identifies cellular processes affecting intracellular aggregation of Alzheimer&#x00027;s amyloid-&#x003B2;42: importance of lipid homeostasis</article-title>. <source>Mol. Biol. Cell</source> <volume>25</volume>, <fpage>2235</fpage>&#x02013;<lpage>2249</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E13-04-0216</pub-id><pub-id pub-id-type="pmid">24870034</pub-id></citation>
</ref>
<ref id="B63">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname> <given-names>T.</given-names></name> <name><surname>Zhu</surname> <given-names>H.</given-names></name> <name><surname>Morishima</surname> <given-names>N.</given-names></name> <name><surname>Li</surname> <given-names>E.</given-names></name> <name><surname>Xu</surname> <given-names>J.</given-names></name> <name><surname>Yankner</surname> <given-names>B. A.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-&#x003B2;</article-title>. <source>Nature</source> <volume>403</volume>, <fpage>98</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1038/47513</pub-id><pub-id pub-id-type="pmid">10638761</pub-id></citation>
</ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname> <given-names>C. S. F.</given-names></name> <name><surname>Pereira</surname> <given-names>H.</given-names></name> <name><surname>Alves</surname> <given-names>S.</given-names></name> <name><surname>Castro</surname> <given-names>L.</given-names></name> <name><surname>Baltazar</surname> <given-names>F.</given-names></name> <name><surname>Chaves</surname> <given-names>S. R.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria</article-title>. <source>Cell Death Dis.</source> <volume>6</volume>, <fpage>e1788</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2015.157</pub-id><pub-id pub-id-type="pmid">26086961</pub-id></citation>
</ref>
<ref id="B65">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orij</surname> <given-names>R.</given-names></name> <name><surname>Urbanus</surname> <given-names>M. L.</given-names></name> <name><surname>Vizeacoumar</surname> <given-names>F. J.</given-names></name> <name><surname>Giaever</surname> <given-names>G.</given-names></name> <name><surname>Boone</surname> <given-names>C.</given-names></name> <name><surname>Nislow</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Genome-wide analysis of intracellular pH reveals quantitative control of cell division rate by pHc in <italic>Saccharomyces cerevisiae</italic></article-title>. <source>Genome Biol.</source> <volume>13</volume>:<fpage>R80</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2012-13-9-r80</pub-id></citation>
</ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Outeiro</surname> <given-names>T. F.</given-names></name> <name><surname>Lindquist</surname> <given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Yeast cells provide insight into alpha-synuclein biology and pathobiology</article-title>. <source>Science</source> <volume>302</volume>, <fpage>1772</fpage>&#x02013;<lpage>1775</lpage>. <pub-id pub-id-type="doi">10.1126/science.1090439</pub-id><pub-id pub-id-type="pmid">14657500</pub-id></citation>
</ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pagani</surname> <given-names>L.</given-names></name> <name><surname>Eckert</surname> <given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Amyloid-Beta interaction with mitochondria</article-title>. <source>Int. J. Alzheimer&#x00027;s Dis.</source> 201<volume>1</volume>:<fpage>925050</fpage>. <pub-id pub-id-type="doi">10.4061/2011/925050</pub-id></citation>
</ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paillusson</surname> <given-names>S.</given-names></name> <name><surname>Stoica</surname> <given-names>R.</given-names></name> <name><surname>Gomez-Suaga</surname> <given-names>P.</given-names></name> <name><surname>Lau</surname> <given-names>D. H. W.</given-names></name> <name><surname>Mueller</surname> <given-names>S.</given-names></name> <name><surname>Miller</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>There&#x00027;s something wrong with my MAM; the ER&#x02013;mitochondria axis and neurodegenerative diseases</article-title>. <source>Trends Neurosci.</source> <volume>39</volume>, <fpage>146</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2016.01.008</pub-id><pub-id pub-id-type="pmid">26899735</pub-id></citation>
</ref>
<ref id="B69">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parrou</surname> <given-names>J. L.</given-names></name> <name><surname>Fran&#x000E7;ois</surname> <given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>A simplified procedure for a rapid and reliable assay of both glycogen and trehalose in whole yeast cells</article-title>. <source>Anal. Biochem.</source> <volume>248</volume>, <fpage>186</fpage>&#x02013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1006/abio.1997.2138</pub-id><pub-id pub-id-type="pmid">9177741</pub-id></citation>
</ref>
<ref id="B70">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pavlov</surname> <given-names>P. F.</given-names></name> <name><surname>Wiehager</surname> <given-names>B.</given-names></name> <name><surname>Sakai</surname> <given-names>J.</given-names></name> <name><surname>Frykman</surname> <given-names>S.</given-names></name> <name><surname>Behbahani</surname> <given-names>H.</given-names></name> <name><surname>Winblad</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Mitochondrial &#x003B3;-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein</article-title>. <source>FASEB J.</source> <volume>25</volume>, <fpage>78</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1096/fj.10-157230</pub-id><pub-id pub-id-type="pmid">20833873</pub-id></citation>
</ref>
<ref id="B71">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piper</surname> <given-names>M. D. W.</given-names></name> <name><surname>Daran-Lapujade</surname> <given-names>P.</given-names></name> <name><surname>Bro</surname> <given-names>C.</given-names></name> <name><surname>Regenberg</surname> <given-names>B.</given-names></name> <name><surname>Knudsen</surname> <given-names>S.</given-names></name> <name><surname>Nielsen</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Reproducibility of oligonucleotide microarray transcriptome analyses: an interlaboratory comparison using chemostat cultures of <italic>Saccharomyces cerevisiae</italic></article-title>. <source>J. Biol. Chem.</source> <volume>277</volume>, <fpage>37001</fpage>&#x02013;<lpage>37008</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M204490200</pub-id><pub-id pub-id-type="pmid">12121991</pub-id></citation>
</ref>
<ref id="B72">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rhein</surname> <given-names>V.</given-names></name> <name><surname>Song</surname> <given-names>X.</given-names></name> <name><surname>Wiesner</surname> <given-names>A.</given-names></name> <name><surname>Ittner</surname> <given-names>L. M.</given-names></name> <name><surname>Baysang</surname> <given-names>G.</given-names></name> <name><surname>Meier</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Amyloid-&#x003B2; and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer&#x00027;s disease mice</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>106</volume>, <fpage>20057</fpage>&#x02013;<lpage>20062</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0905529106</pub-id><pub-id pub-id-type="pmid">19897719</pub-id></citation>
</ref>
<ref id="B73">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname> <given-names>A. A.</given-names></name> <name><surname>Voeltz</surname> <given-names>G. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Endoplasmic reticulum-mitochondria contacts: function of the junction</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>13</volume>, <fpage>607</fpage>&#x02013;<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3440</pub-id><pub-id pub-id-type="pmid">22992592</pub-id></citation>
</ref>
<ref id="B74">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruffin</surname> <given-names>V. A.</given-names></name> <name><surname>Salameh</surname> <given-names>A. I.</given-names></name> <name><surname>Boron</surname> <given-names>W. F.</given-names></name> <name><surname>Parker</surname> <given-names>M. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Intracellular pH regulation by acid-base transporters in mammalian neurons</article-title>. <source>Front. Physiol.</source> <volume>5</volume>:<fpage>43</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00043</pub-id><pub-id pub-id-type="pmid">24592239</pub-id></citation>
</ref>
<ref id="B75">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rutkowski</surname> <given-names>D. T.</given-names></name> <name><surname>Arnold</surname> <given-names>S. M.</given-names></name> <name><surname>Miller</surname> <given-names>C. N.</given-names></name> <name><surname>Wu</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Gunnison</surname> <given-names>K. M.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins</article-title>. <source>PLoS Biol.</source> <volume>4</volume>:<fpage>e374</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.0040374</pub-id><pub-id pub-id-type="pmid">17090218</pub-id></citation>
</ref>
<ref id="B76">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawamura</surname> <given-names>N.</given-names></name> <name><surname>Ko</surname> <given-names>M.</given-names></name> <name><surname>Yu</surname> <given-names>W.</given-names></name> <name><surname>Zou</surname> <given-names>K.</given-names></name> <name><surname>Hanada</surname> <given-names>K.</given-names></name> <name><surname>Suzuki</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Modulation of amyloid precursor protein cleavage by cellular sphingolipids</article-title>. <source>J. Biol. Chem.</source> <volume>279</volume>, <fpage>11984</fpage>&#x02013;<lpage>11991</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M309832200</pub-id><pub-id pub-id-type="pmid">14715666</pub-id></citation>
</ref>
<ref id="B77">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scheper</surname> <given-names>W.</given-names></name> <name><surname>Hoozemans</surname> <given-names>J. J. M.</given-names></name></person-group> (<year>2015</year>). <article-title>The unfolded protein response in neurodegenerative diseases: a neuropathological perspective</article-title>. <source>Acta Neuropathol.</source> <volume>130</volume>, <fpage>315</fpage>&#x02013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-015-1462-8</pub-id><pub-id pub-id-type="pmid">26210990</pub-id></citation>
</ref>
<ref id="B78">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selfridge</surname> <given-names>J. E.</given-names></name> <name><surname>Lezi</surname> <given-names>E.</given-names></name> <name><surname>Lu</surname> <given-names>J.</given-names></name> <name><surname>Swerdlow</surname> <given-names>R. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of mitochondrial homeostasis and dynamics in Alzheimer&#x00027;s disease</article-title>. <source>Neurobiol. Dis.</source> <volume>51</volume>, <fpage>3</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2011.12.057</pub-id><pub-id pub-id-type="pmid">22266017</pub-id></citation>
</ref>
<ref id="B79">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selkoe</surname> <given-names>D. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Alzheimer&#x00027;s disease: genes, proteins, and therapy</article-title>. <source>Physiol. Rev.</source> <volume>81</volume>, <fpage>741</fpage>&#x02013;<lpage>766</lpage>. <pub-id pub-id-type="pmid">11274343</pub-id></citation>
</ref>
<ref id="B80">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shankar</surname> <given-names>G. M.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Mehta</surname> <given-names>T. H.</given-names></name> <name><surname>Garcia-Munoz</surname> <given-names>A.</given-names></name> <name><surname>Shepardson</surname> <given-names>N. E.</given-names></name> <name><surname>Smith</surname> <given-names>I.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Amyloid-[&#x003B2;] protein dimers isolated directly from Alzheimer&#x00027;s brains impair synaptic plasticity and memory</article-title>. <source>Nat. Med.</source> <volume>14</volume>, <fpage>837</fpage>&#x02013;<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1038/nm1782</pub-id><pub-id pub-id-type="pmid">18568035</pub-id></citation>
</ref>
<ref id="B81">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shokouhi</surname> <given-names>S.</given-names></name> <name><surname>Claassen</surname> <given-names>D.</given-names></name> <name><surname>Kang</surname> <given-names>H.</given-names></name> <name><surname>Ding</surname> <given-names>Z.</given-names></name> <name><surname>Rogers</surname> <given-names>B.</given-names></name> <name><surname>Mishra</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG pet</article-title>. <source>J. Nuclear Med.</source> <volume>54</volume>, <fpage>1564</fpage>&#x02013;<lpage>1569</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.112.116137</pub-id><pub-id pub-id-type="pmid">23864720</pub-id></citation>
</ref>
<ref id="B82">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname> <given-names>M.</given-names></name> <name><surname>Keller</surname> <given-names>P.</given-names></name> <name><surname>De Strooper</surname> <given-names>B.</given-names></name> <name><surname>Beyreuther</surname> <given-names>K.</given-names></name> <name><surname>Dotti</surname> <given-names>C. G.</given-names></name> <name><surname>Simons</surname> <given-names>K.</given-names></name></person-group> (<year>1998</year>). <article-title>Cholesterol depletion inhibits the generation of &#x003B2;-amyloid in hippocampal neurons</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>95</volume>, <fpage>6460</fpage>&#x02013;<lpage>6464</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.11.6460</pub-id><pub-id pub-id-type="pmid">9600988</pub-id></citation>
</ref>
<ref id="B83">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname> <given-names>M. A.</given-names></name> <name><surname>Lindquist</surname> <given-names>S.</given-names></name></person-group> (<year>1998</year>). <article-title>Multiple effects of trehalose on protein folding <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>Mol. Cell</source> <volume>1</volume>, <fpage>639</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/S1097-2765(00)80064-7</pub-id><pub-id pub-id-type="pmid">9660948</pub-id></citation>
</ref>
<ref id="B84">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sparks</surname> <given-names>D. L.</given-names></name> <name><surname>Scheff</surname> <given-names>S. W.</given-names></name> <name><surname>Hunsaker</surname> <given-names>J. C.</given-names> <suffix>III</suffix></name> <name><surname>Liu</surname> <given-names>H.</given-names></name> <name><surname>Landers</surname> <given-names>T.</given-names></name> <name><surname>Gross</surname> <given-names>D. R.</given-names></name></person-group> (<year>1994</year>). <article-title>Induction of Alzheimer-like &#x003B2;-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol</article-title>. <source>Exp. Neurol.</source> <volume>126</volume>, <fpage>88</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1006/exnr.1994.1044</pub-id><pub-id pub-id-type="pmid">8157129</pub-id></citation>
</ref>
<ref id="B85">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoica</surname> <given-names>R.</given-names></name> <name><surname>De Vos</surname> <given-names>K. J.</given-names></name> <name><surname>Paillusson</surname> <given-names>S.</given-names></name> <name><surname>Mueller</surname> <given-names>S.</given-names></name> <name><surname>Sancho</surname> <given-names>R. M.</given-names></name> <name><surname>Lau</surname> <given-names>K.-F.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>ER&#x02013;mitochondria associations are regulated by the VAPB&#x02013;PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43</article-title>. <source>Nat. Commun.</source> <volume>5</volume>:<fpage>3996</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms4996</pub-id><pub-id pub-id-type="pmid">24893131</pub-id></citation>
</ref>
<ref id="B86">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strittmatter</surname> <given-names>W. J.</given-names></name> <name><surname>Saunders</surname> <given-names>A. M.</given-names></name> <name><surname>Schmechel</surname> <given-names>D.</given-names></name> <name><surname>Pericak-Vance</surname> <given-names>M.</given-names></name> <name><surname>Enghild</surname> <given-names>J.</given-names></name> <name><surname>Salvesen</surname> <given-names>G. S.</given-names></name> <etal/></person-group>. (<year>1993</year>). <article-title>Apolipoprotein E: high-avidity binding to &#x003B2;-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>90</volume>, <fpage>1977</fpage>&#x02013;<lpage>1981</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.90.5.1977</pub-id><pub-id pub-id-type="pmid">8446617</pub-id></citation>
</ref>
<ref id="B87">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Syntichaki</surname> <given-names>P.</given-names></name> <name><surname>Samara</surname> <given-names>C.</given-names></name> <name><surname>Tavernarakis</surname> <given-names>N.</given-names></name></person-group> (<year>2005</year>). <article-title>The vacuolar H<sup>&#x0002B;</sup>-ATPase mediates intracellular acidification required for neurodegeneration in <italic>C</italic>. elegans</article-title>. <source>Curr. Biol.</source> <volume>15</volume>, <fpage>1249</fpage>&#x02013;<lpage>1254</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2005.05.057</pub-id><pub-id pub-id-type="pmid">16005300</pub-id></citation>
</ref>
<ref id="B88">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szegezdi</surname> <given-names>E.</given-names></name> <name><surname>Logue</surname> <given-names>S. E.</given-names></name> <name><surname>Gorman</surname> <given-names>A. M.</given-names></name> <name><surname>Samali</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Mediators of endoplasmic reticulum stress-induced apoptosis</article-title>. <source>EMBO Rep.</source> <volume>7</volume>, <fpage>880</fpage>&#x02013;<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1038/sj.embor.7400779</pub-id><pub-id pub-id-type="pmid">16953201</pub-id></citation>
</ref>
<ref id="B89">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thibault</surname> <given-names>G.</given-names></name> <name><surname>Ismail</surname> <given-names>N.</given-names></name> <name><surname>Ng</surname> <given-names>D. T. W.</given-names></name></person-group> (<year>2011</year>). <article-title>The unfolded protein response supports cellular robustness as a broad-spectrum compensatory pathway</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>108</volume>, <fpage>20597</fpage>&#x02013;<lpage>20602</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1117184109</pub-id><pub-id pub-id-type="pmid">22143797</pub-id></citation>
</ref>
<ref id="B90">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thinakaran</surname> <given-names>G.</given-names></name> <name><surname>Koo</surname> <given-names>E. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Amyloid precursor protein trafficking, processing, and function</article-title>. <source>J. Biol. Chem.</source> <volume>283</volume>, <fpage>29615</fpage>&#x02013;<lpage>29619</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R800019200</pub-id><pub-id pub-id-type="pmid">18650430</pub-id></citation>
</ref>
<ref id="B91">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Travers</surname> <given-names>K. J.</given-names></name> <name><surname>Patil</surname> <given-names>C. K.</given-names></name> <name><surname>Wodicka</surname> <given-names>L.</given-names></name> <name><surname>Lockhart</surname> <given-names>D. J.</given-names></name> <name><surname>Weissman</surname> <given-names>J. S.</given-names></name> <name><surname>Walter</surname> <given-names>P.</given-names></name></person-group> (<year>2000</year>). <article-title>Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation</article-title>. <source>Cell</source> <volume>101</volume>, <fpage>249</fpage>&#x02013;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80835-1</pub-id><pub-id pub-id-type="pmid">10847680</pub-id></citation>
</ref>
<ref id="B92">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Treusch</surname> <given-names>S.</given-names></name> <name><surname>Hamamichi</surname> <given-names>S.</given-names></name> <name><surname>Goodman</surname> <given-names>J. L.</given-names></name> <name><surname>Matlack</surname> <given-names>K. E. S.</given-names></name> <name><surname>Chung</surname> <given-names>C. Y.</given-names></name> <name><surname>Baru</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Functional links between A&#x003B2; toxicity, endocytic trafficking and Alzheimer&#x00027;s disease risk factors in yeast</article-title>. <source>Science</source> <volume>334</volume>, <fpage>1241</fpage>&#x02013;<lpage>1245</lpage>. <pub-id pub-id-type="doi">10.1126/science.1213210</pub-id><pub-id pub-id-type="pmid">22033521</pub-id></citation>
</ref>
<ref id="B93">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Umeda</surname> <given-names>T.</given-names></name> <name><surname>Tomiyama</surname> <given-names>T.</given-names></name> <name><surname>Sakama</surname> <given-names>N.</given-names></name> <name><surname>Tanaka</surname> <given-names>S.</given-names></name> <name><surname>Lambert</surname> <given-names>M. P.</given-names></name> <name><surname>Klein</surname> <given-names>W. L.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Intraneuronal amyloid &#x003B2; oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction <italic>in vivo</italic></article-title>. <source>J. Neurosci. Res.</source> <volume>89</volume>, <fpage>1031</fpage>&#x02013;<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.22640</pub-id><pub-id pub-id-type="pmid">21488093</pub-id></citation>
</ref>
<ref id="B94">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>V&#x000E4;remo</surname> <given-names>L.</given-names></name> <name><surname>Nielsen</surname> <given-names>J.</given-names></name> <name><surname>Nookaew</surname> <given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume>, <fpage>4378</fpage>&#x02013;<lpage>4391</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt111</pub-id><pub-id pub-id-type="pmid">23444143</pub-id></citation>
</ref>
<ref id="B95">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Verduyckt</surname> <given-names>M.</given-names></name> <name><surname>Vignaud</surname> <given-names>H.</given-names></name> <name><surname>Bynens</surname> <given-names>T.</given-names></name> <name><surname>Van Den Brande</surname> <given-names>J.</given-names></name> <name><surname>Franssens</surname> <given-names>V.</given-names></name> <name><surname>Cullin</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Yeast as a model for Alzheimer&#x00027;s disease: latest studies and advanced strategies</article-title>, in <source>Systems Biology of Alzheimer&#x00027;s Disease</source>, eds <person-group person-group-type="editor"><name><surname>Castrillo</surname> <given-names>J. I.</given-names></name> <name><surname>Oliver</surname> <given-names>S. G.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Humana Press</publisher-name>), <fpage>197</fpage>&#x02013;<lpage>215</lpage>.</citation>
</ref>
<ref id="B96">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verghese</surname> <given-names>P. B.</given-names></name> <name><surname>Castellano</surname> <given-names>J. M.</given-names></name> <name><surname>Garai</surname> <given-names>K.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Jiang</surname> <given-names>H.</given-names></name> <name><surname>Shah</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>ApoE influences amyloid-&#x003B2; (A&#x003B2;) clearance despite minimal apoE/A&#x003B2; association in physiological conditions</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>110</volume>, <fpage>E1807</fpage>&#x02013;<lpage>E1816</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1220484110</pub-id><pub-id pub-id-type="pmid">23620513</pub-id></citation>
</ref>
<ref id="B97">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>von der Haar</surname> <given-names>T.</given-names></name> <name><surname>Joss&#x000E9;</surname> <given-names>L.</given-names></name> <name><surname>Wright</surname> <given-names>P.</given-names></name> <name><surname>Zenthon</surname> <given-names>J.</given-names></name> <name><surname>Tuite</surname> <given-names>M. F.</given-names></name></person-group> (<year>2007</year>). <article-title>Development of a novel yeast cell-based system for studying the aggregation of Alzheimer&#x00027;s disease-associated A&#x003B2; peptides <italic>in vivo</italic></article-title>. <source>Neurodegenerative Dis.</source> <volume>4</volume>, <fpage>136</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1159/000101838</pub-id><pub-id pub-id-type="pmid">17596708</pub-id></citation>
</ref>
<ref id="B98">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname> <given-names>J.</given-names></name> <name><surname>van Echten-Deckert</surname> <given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Cross-talk of membrane lipids and Alzheimer-related proteins</article-title>. <source>Mol. Neurodegener.</source> <volume>8</volume>, <fpage>34</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1186/1750-1326-8-34</pub-id><pub-id pub-id-type="pmid">24148205</pub-id></citation>
</ref>
<ref id="B99">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Su</surname> <given-names>B.</given-names></name> <name><surname>Siedlak</surname> <given-names>S. L.</given-names></name> <name><surname>Moreira</surname> <given-names>P. I.</given-names></name> <name><surname>Fujioka</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Amyloid-&#x003B2; overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>105</volume>, <fpage>19318</fpage>&#x02013;<lpage>19323</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0804871105</pub-id><pub-id pub-id-type="pmid">19050078</pub-id></citation>
</ref>
<ref id="B100">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname> <given-names>P. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Lipidomics of Alzheimer&#x00027;s disease: current status</article-title>. <source>Alzheimer&#x00027;s Res. Ther.</source> <volume>4</volume>, <fpage>5</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1186/alzrt103</pub-id><pub-id pub-id-type="pmid">22293144</pub-id></citation>
</ref>
<ref id="B101">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wyss-Coray</surname> <given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Ageing, neurodegeneration and brain rejuvenation</article-title>. <source>Nature</source> <volume>539</volume>, <fpage>180</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1038/nature20411</pub-id><pub-id pub-id-type="pmid">27830812</pub-id></citation>
</ref>
<ref id="B102">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamane</surname> <given-names>T.</given-names></name> <name><surname>Ikari</surname> <given-names>Y.</given-names></name> <name><surname>Nishio</surname> <given-names>T.</given-names></name> <name><surname>Ishii</surname> <given-names>K.</given-names></name> <name><surname>Ishii</surname> <given-names>K.</given-names></name> <name><surname>Kato</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Visual-statistical interpretation of 18F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation</article-title>. <source>Am. J. Neuroradiol.</source> <volume>35</volume>, <fpage>244</fpage>&#x02013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A3665</pub-id></citation>
</ref>
<ref id="B103">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>J.</given-names></name> <name><surname>Irwin</surname> <given-names>R. W.</given-names></name> <name><surname>Zhao</surname> <given-names>L.</given-names></name> <name><surname>Nilsen</surname> <given-names>J.</given-names></name> <name><surname>Hamilton</surname> <given-names>R. T.</given-names></name> <name><surname>Brinton</surname> <given-names>R. D.</given-names></name></person-group> (<year>2009</year>). <article-title>Mitochondrial bioenergetic deficit precedes Alzheimer&#x00027;s pathology in female mouse model of Alzheimer&#x00027;s disease</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>106</volume>, <fpage>14670</fpage>&#x02013;<lpage>14675</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0903563106</pub-id><pub-id pub-id-type="pmid">19667196</pub-id></citation>
</ref>
<ref id="B104">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Younkin</surname> <given-names>S. G.</given-names></name></person-group> (<year>1998</year>). <article-title>The role of A&#x003B2;42 in Alzheimer&#x00027;s disease</article-title>. <source>J. Physiol. Paris</source> <volume>92</volume>, <fpage>289</fpage>&#x02013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/S0928-4257(98)80035-1</pub-id></citation>
</ref>
<ref id="B105">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Komano</surname> <given-names>H.</given-names></name> <name><surname>Fuller</surname> <given-names>R. S.</given-names></name> <name><surname>Gandy</surname> <given-names>S. E.</given-names></name> <name><surname>Frail</surname> <given-names>D. E.</given-names></name></person-group> (<year>1994</year>). <article-title>Proteolytic processing and secretion of human beta-amyloid precursor protein in yeast. Evidence for a yeast secretase activity</article-title>. <source>J. Biol. Chem.</source> <volume>269</volume>, <fpage>27799</fpage>&#x02013;<lpage>27802</lpage>. <pub-id pub-id-type="pmid">7961704</pub-id></citation>
</ref>
<ref id="B106">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Malhotra</surname> <given-names>J.</given-names></name> <name><surname>Hassler</surname> <given-names>J. R.</given-names></name> <name><surname>Back</surname> <given-names>S. H.</given-names></name> <name><surname>Wang</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>The unfolded protein response transducer IRE1&#x003B1; prevents ER stress-induced hepatic steatosis</article-title>. <source>EMBO J.</source> <volume>30</volume>, <fpage>1357</fpage>&#x02013;<lpage>1375</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.52</pub-id><pub-id pub-id-type="pmid">21407177</pub-id></citation>
</ref>
<ref id="B107">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y. J.</given-names></name> <name><surname>Buijs</surname> <given-names>N. A.</given-names></name> <name><surname>Zhu</surname> <given-names>Z.</given-names></name> <name><surname>Qin</surname> <given-names>J.</given-names></name> <name><surname>Siewers</surname> <given-names>V.</given-names></name> <name><surname>Nielsen</surname> <given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Production of fatty acid-derived oleochemicals and biofuels by synthetic yeast cell factories</article-title>. <source>Nat. Commun.</source> <volume>7</volume>:<fpage>11709</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms11709</pub-id><pub-id pub-id-type="pmid">27222209</pub-id></citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was funded by grants from Novo Nordisk Foundation (21210022).</p>
</fn>
</fn-group>
</back>
</article>